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ABSTRACT 
 Aging is associated with a loss of cognitive function related to learning, memory, 
and executive function with varying severity. Although there is no age-related loss of 
neurons in healthy aging, myelin damage accumulates and is associated with cognitive 
decline. The brain’s resident macrophages, microglia, are responsible for clearing damaged 
myelin and promoting subsequent oligodendrocyte-mediated remyelination. To test the 
hypothesis that age-related dysfunction of microglial phagocytosis and oligodendrocyte 
remyelination capacity contributes to myelin pathology and cognitive impairment. To test 
this, rhesus monkeys from across the lifespan (7-30 years of age) were tested in three 
specific aims. 1) To characterize gene expression of myelin basic protein (MBP) in the 
brain and clearance of MBP to the cerebrospinal fluid (CSF) in relation to age-related 
myelin pathology. The density of myelinated axons visualized using label-free spectral 
confocal reflectance imaging did not correlate with age, but was significantly lower in aged 
animals with cognitive impairment. Next, MBP gene expression was measured using qPCR 
in the dorsal prefrontal cortex along with quantification of MBP protein levels in the CSF 
using ELISA. Age-dependent increases of MBP gene expression in the brain and MBP 
protein levels in the CSF were observed. Interestingly, MBP levels in the CSF were lower 
  vi 
in animals with cognitive impairment. 2) To test the hypothesis that microglia would 
become increasingly primed for phagocytosis with age-related myelin pathology. The 
number of microglia immunostained with galectin-3, a marker for phagocytic activation, 
was quantified in the frontal white matter and increases in both aging and cognitive decline 
were detected. 3) To evaluate the hypothesis that lipofuscin, an age-related accumulation 
indicative of autophagic dysfunction, would accumulate and impair glial cells of the white 
matter in aged animals. Lipofuscin accumulation was increased with age in the frontal 
white matter and the size of lipofuscin clusters was associated with cognitive impairment. 
Lipofuscin was found primarily in microglia and oligodendrocytes, but not in astrocytes. 
These data suggest that lipofuscin burden in microglia and oligodendrocytes inhibits their 
homeostatic functions resulting in improper myelin clearance and turnover, leading to a 
devastating feed-forward cycle of myelin damage that contributes to age-related cognitive 
impairment.  
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CHAPTER 1: INTRODUCTION 
 Age-related cognitive decline is known to occur both in health and disease, particularly 
in the domains of memory, processing speed, and executive function (Brayne et al. 1995; 
Cullum et al. 2000; Salthouse 2010; Singh-Manoux et al. 2012). While Alzheimer's disease 
(AD) is the devastating age-related dementia most often associated with cognitive decline, 
for those who escape AD, aging is accompanied by noticeable, but less severe cognitive 
impairment that affects individuals at different rates (Fjell and Walhovd 2010). Age-related 
cognitive decline is known to occur both in health and disease, particularly in the domains 
of memory, processing speed, and executive function (Brayne et al. 1995; Cullum et al. 
2000; Salthouse 2010; Singh-Manoux et al. 2012). While Alzheimer's disease (AD) is the 
devastating age-related dementia most often associated with cognitive decline, for those 
who escape AD, aging is accompanied by noticeable, but less severe cognitive impairment 
that affects individuals at different rates (Fjell and Walhovd 2010). Rather than cell loss, 
the cognitive decline of normal aging comes with a distinct white matter pathology, 
accompanied by loss of synaptic connections, that is most severe in the frontal regions 
(Salat et al. 2004; Abe et al. 2008; Fjell et al. 2009). Although the cause of the white matter 
pathology is poorly understood, it has been linked to deficits in myelin – the insulating 
sheath on axonal fibers that enhances conduction of signals across interconnected brain 
areas. The brain’s immune system may play a role by failing to clear damaged myelin 
debris or even by directly damaging white matter. In this review, we will present the 
evidence of a connection between the aging of the neuroimmune system and the 
pathologies of normal aging and normal cognitive aging (NCA). We hope to demonstrate 
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that although great strides have been made in our understanding of normal cognitive aging, 
a greater focus on neuroimmunology of the white matter may elucidate the cause of the 
underlying pathology. In this review, we will present the evidence of a connection between 
the aging of the neuroimmune system and the pathologies of normal aging and normal 
cognitive aging (NCA). We hope to demonstrate that although great strides have been made 
in our understanding of normal cognitive aging, a greater focus on neuroimmunology of 
the white matter may elucidate the cause of the underlying pathology. 
Pathology of Alzheimer’s disease – neuronal loss and the hippocampus 
 Although aging is the greatest predictor of AD (Alzheimer’s Association 2013; 
Guerreiro et al. 2015), the symptoms and pathology of aging and AD must be separated to 
be fully understood. Most commonly, AD affects the cognitive domains of short-term 
memory and executive function and is characterized by the slow, progressive loss of 
function over time (McKhann et al. 2011). The well-documented pathology that defines 
AD centers on neurodegeneration starting in the hippocampal formation in the medial 
temporal lobe. Preceding clinical symptoms by a decade, and potentially causing the 
neuronal loss, is the accumulation of amyloid beta plaques (Aβ plaques) and intracellular 
neurofibrillary tangles of phosphorylated tau (pTau) (Ringman et al. 2008; Bateman et al. 
2012). Eventually this degeneration spreads beyond the hippocampal formation to other 
brain regions causing multi-domain cognitive dysfunctions (see Masters et al. 2015). 
Pathology of normal cognitive aging – white matter and myelin 
 Unlike the neurodegeneration of AD, a consistent finding of healthy aging and NCA is 
that neurons are not lost with age in humans (Terry et al. 1987; Freeman et al. 2008). 
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However, non-neurodegenerative aging is still associated with a decrease in cognitive 
function, particularly in the domains of memory, processing speed, and executive function 
(Brayne et al. 1995; Cullum et al. 2000; Salthouse 2010; Singh-Manoux et al. 2012). 
Despite a lack of neuronal loss, MRI studies have determined that gray matter volume 
appears to decline slowly with age beginning in early adulthood (Courchesne et al. 2000; 
Good et al. 2001; Storsve et al. 2014). White matter, however, does not begin to show 
alterations until late middle-age (40-60 years old) at which point volume begins to decrease 
(Albert 1993; Guttmann et al. 1998; Jernigan and Gamst 2005; Fjell and Walhovd 2010). 
In addition to volumetric loss, researchers have also identified white matter 
hyperintensities, age-related lesions that can be visualized with MRI and correlate with 
cognitive decline (De Groot et al. 2000; de Leeuw et al. 2001; Prins and Scheltens 2015). 
With diffusion tensor imaging (DTI) fractional anisotropy (FA) to measure what is thought 
to be myelin integrity (Moseley 2002; Sullivan and Pfefferbaum 2006), decreases with age 
(Charlton et al. 2006; Voineskos et al. 2012; Teipel et al. 2014). Unlike AD, where disease 
progression seems to begin in the temporal lobe, age-related loss of both gray and white 
matter volume begin in the frontal lobe (Salat et al. 2004; Abe et al. 2008; Fjell et al. 2009). 
The regional volume differences between normal aging and AD brains make for a useful 
diagnostic parameter to distinguish AD from NCA (Head et al. 2005; Raji et al. 2009; Fjell 
et al. 2010). 
 In contrast to non-invasive MRI studies of the human brain, postmortem studies of the 
aging human brain are difficult as preservation of tissue for histological or molecular 
studies is often confounded by post-mortem delay in tissue harvest. In addition, while 
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donations from elderly subjects with and without AD are often available, obtaining healthy 
younger adults brains is very difficult. Nevertheless, the studies that have been done largely 
corroborate the volumetric studies with MRI. Age-related loss of gray matter volume is 
thought to reflect neuronal shrinkage (Terry et al. 1987) and decreases in dendritic 
arborization (Anderson and Rutledge 1996; Jacobs et al. 1997; Esiri 2007). In the white 
matter, histological and electron microscopic studies have estimated an age-related 
myelinated fiber decrease by 27% to 45% (Tang et al. 1997; Marner et al. 2003). 
 For the reasons mentioned previously, researchers attempting to understand the cellular 
and molecular basis of aging have often turned to animal models. Similar to humans, the 
rhesus monkey develops cognitive decline with age but does not have neurodegenerative 
AD pathology (Sloane et al. 1997; Peters et al. 1998; Peters and Rosene 2003).  MRI data 
from rhesus monkeys, similar to human, have shown an age-related decrease in white 
matter volume with little gray matter loss (Wisco et al. 2008). Additionally, myelin 
integrity, assessed by DTI, also decreases with age in the monkey (Makris et al. 2007). Our 
lab has used rhesus monkey animal model to find ultrastructural evidence of age-related 
myelin fiber loss and myelin damage in the cingulum bundle and corpus callosum (Bowley 
et al. 2010), the anterior commissure (Sandell and Peters 2003), fornix (Peters et al. 2010), 
the optic nerve (Sandell and Peters 2002) and the visual cortex (Peters et al. 2000). 
Importantly, we have also shown that the age-related myelin damage is also correlated with 
decreased cognitive performance (Bowley et al. 2010). 
 Based on the literature, it is clear that Alzheimer’s disease and normal cognitive aging 
are distinct pathologies and should be treated as such, rather than a continuum of the same 
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spectrum. White matter pathology caused by myelin damage is likely the main culprit of 
cognitive decline in normal aging, but little is known as to why myelination becomes faulty 
with age. We suggest two potential glial mechanisms that may underlie myelin damage: 
oligodendrocytes and microglia. Oligodendrocytes, as the cell responsible for creating and 
maintaining the myelin sheath, may have age-related defects in the ability to produce, 
maintain myelin or remyelinate after damage (Shields et al. 1999; Ruckh et al. 2012). 
Alternatively, age-related microglial dysfunction may lead to the inability of these resident 
macrophages of the brain to clear debris, leaving damaged myelin byproducts to linger 
(Safaiyan et al. 2016). For the remainder of this review, we will focus on microglia and the 
brain’s immune system to show what is known and unknown about microglia and how they 
may be involved in myelin damage. We present evidence from the literature that suggest 
that microglia are at the center of a delicate balance surrounding normal myelination. 
Understanding the age-related functional alterations in microglia may be the key to 
understanding the causes of myelin pathology and normal cognitive aging. 
Microglia and aging 
 Neuroimmunology has been at the forefront of aging and AD research. But we argue 
that, like general aging research, neuroimmunologists have limited their attention to 
neuronal loss, particularly in the hippocampus, in neurodegenerative disease, and largely 
ignored normal cognitive aging. In the previous sections, we noted that both dendritic 
atrophy and spine loss as well as myelin damage are likely the major contributors to normal 
cognitive aging in humans and monkeys. Both the processes of spine pruning and 
remyelination are known to involve the brain’s immune system and resident macrophage 
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known as microglia. Microglia are yolk-sac derived myeloid cells originally thought to be 
only responsible for phagocytosis and the innate immune response in the brain (Alliot et 
al. 1999; Ginhoux et al. 2010). However, recent research has shed light on microglial 
functions outside of their immune duties.  
 Two decades ago, microglia were thought to be “resting” or “quiescent” when not 
“activated” for inflammation. While these terms still linger, researchers have made a 
concerted effort to move into more functionally relevant terminology. First, microglia are 
now known to not be “resting”, but actively surveilling the environment (Nimmerjahn et 
al. 2005). In gray matter, microglia are responsible for sculpting and pruning synapses 
(Stevens et al. 2007; Schafer et al. 2012), a function that continues throughout life (Stephan 
et al. 2012; Parkhurst et al. 2013). Although we do not know the role of microglia synaptic 
pruning in disease, there is an upregulation of complement and concurrent synaptic loss in 
age-related dementia that implicates microglia (Chung et al. 2015).  
 Aging can cause microglia to become dystrophic and potentially senescent (Streit et al. 
2004). Immune challenge in old mice can cause a shift in microglia to an inflammatory 
morphology and an M1/pro-inflammatory phenotype (Godbout et al. 2005). Additionally, 
microglia isolated from old mice have a higher expression of both M1 and M2/anti-
inflammatory cytokines and an altered M2 response to challenge with lipopolysaccharide 
(Sierra et al. 2007). While the traditional inflammatory dichotomy of M1/M2 microglia has 
been useful for understanding the basics of inflammatory processes, the most recent 
advances in neuroimmunology have demonstrated that the M1/M2 binary is too simplistic 
to truly represent microglia functions and responses (Ransohoff 2016). Using RNA 
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sequencing (RNAseq), researchers have discovered that microglia responses are often 
unconstrained by traditional schema, and “M1” or “M2” associated proteins can actually 
be expressed together (Kim et al. 2016) and gene expression can demonstrate 
transcriptional signatures of differing disease states (Holtman et al. 2015). Therefore, 
moving beyond the M1/M2 dichotomy is imperative in determining how microglial 
function is changing with age.  
 Recent studies using RNAseq have identified a microglial signature distinct from 
peripheral macrophages which identifies key transcriptional differences between the two 
cell types. This includes finding a microglial ‘sensome’ comprised of transcripts that mark 
microglial surveillance (Hickman et al. 2013; Butovsky et al. 2014). While Hickman et al 
(2013) found an age-related shift towards transcripts involved in neuroprotection and 
repair, others have reported an increase in phagocytic, lysosomal and antigen-presentation 
transcripts. Unsurprisingly, aging caused significant differences in microglia transcription 
profiles in different regions of the brain (Grabert et al. 2016). 
 A major constraint to RNAseq that has limited our understanding of the human 
microglial transcriptome and age-related changes is the requirement of fresh, unfixed tissue 
to isolate microglia. Studies investigating human microglia transcriptomes have taken 
brain tissue biopsied during surgery, generally from the cortex, or taken from donors 
immediately post mortem. In both scenarios, acquiring healthy, "normal" tissue is rare, 
given the requirements. From the data that have been gathered, microglial profiles of mice 
and humans diverge with age, as human microglia have altered transcripts related to 
neurodegenerative diseases and are distinct from the gene expression changes seen in the 
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aging mouse (Galatro et al. 2017; Gosselin et al. 2017). In aging, human microglia have 
changes to transcripts involved in cell adhesion, axonal guidance, and the sensome that are 
distinct from the transcriptional changes seen in the aging mouse (Galatro et al. 2017).  
 Although the presented data offer compelling evidence for microglial alterations in 
aging, there are some major confounds to understanding the state of microglia in the aging 
brain. First, microglial cultures have provided a great deal of data, but microglia are 
extremely context/environment dependent and quickly lose their transcriptional signature 
in culture (Gosselin et al. 2017). Second, human microglial studies are only able to use 
tissue from cases where disease is present justifying the cortical brain biopsy. Third, the 
only other source of tissue is from post mortem studies. This makes it difficult to be 
confident that the results reflect non-diseased human microglia, especially in human aging 
where neurodegenerative disease is frequently present. Finally, none of the human studies 
are able to address the transcriptional profiles of microglia in the white matter.  
Microglia in the white matter 
 Thus far, our knowledge of aging microglia has come almost exclusively from the gray 
matter of human and mouse brains. As an entire mouse brain consists of 90% gray matter 
(Zhang and Sejnowski 2000), it allows comparison to human cortical gray matter studies 
of microglia, but limits what can be known about the major pathology of aging, white 
matter damage. This is a major deficit in our knowledge for myelin pathology for several 
reasons. First, microglia are necessary for oligodendrocyte differentiation and maturation 
(Miron et al. 2013) and for remyelination (Lampron et al. 2015). Furthermore, age-related 
myelin damage impairs microglial phagocytic function in the mouse (Safaiyan et al. 2016). 
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It is therefore very likely that microglia play an important non-immune role in the white 
matter, likely in the homeostatic maintenance of myelin.  
 Interestingly, aging is associated with an increase in inflammation particularly in the 
white matter (Hart et al. 2012; Raj et al. 2017; Shobin et al. 2017). Our lab, using the rhesus 
monkey model of normal aging, has shown that phagocytic priming increases in microglia 
with age but only in the white matter (Shobin et al. 2017). The observation that there are 
similar upregulations of genes related to innate immunity in both the AD brain and the 
‘healthy’ aged brain (Cribbs et al. 2012) suggests that neuroinflammation is a feature of 
aging that occurs independent of neurodegeneration. Nevertheless, studies of 
neuroinflammation and aging have primarily focused on the gray matter even though white 
matter damage is a major feature of normal aging pathology. In PubMed, a search for the 
terms “microglia” and “aging” yields 1763 results. Adding in the term “neuron” reduces 
this to 771, but adding in “myelin” brings up only 72 articles (as of February, 10, 2018).  
 White matter microglial research is still in its very early stages and an abundance of 
foundational questions are left to be answered. What roles do microglia in the white matter 
play outside of their jobs as immune cells? We have reports that these cells are involved in 
remyelination and oligodendrocyte differentiation (Miron et al. 2013; Lampron et al. 
2015), but the extent of this is unknown. With very limited knowledge of white matter 
microglia, we assume that all microglia are equal, but with such a strong tie to environment 
(Gosselin et al. 2017) it would not be surprising to find that microglia in the gray matter 
and white matter function differently. Finally, is inflammation in the white matter a cause 
of white matter dysfunction, resulting from problematic white matter microglia, or is it 
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merely a response to age-related deterioration of myelin and/or myelinating 
oligodendrocytes?  
Microglia in normal cognitive aging and AD 
 Streit et al (2005) hypothesized that dystrophic or senescent microglia seen in humans 
are functionally impaired and may be contribute to normal cognitive aging but few studies 
have specifically examined microglia in relation to cognitive aging. As an example of 
microglia dysfunction with age, peripheral immune challenge in older mice causes both 
increased microglial inflammation and cognitive decline but the same effects do not occur 
when young mice are challenged (Barrientos et al. 2006). High levels of IL-1β, a pro-
inflammatory cytokine produced by microglia, can impair memory and synaptic plasticity 
(see Patterson 2015). Hypomethylation of the IL-1β gene increases with age and can cause 
an increase in IL-1β production that correlates with cognitive impairment (Cho et al. 2015). 
We have reported that white matter microglial inflammation and phagocytic priming 
correlate with cognitive impairment in aging monkeys (Sloane et al. 1999; Shobin et al. 
2017). In humans, cortical inflammatory microglia measured with positron emission 
tomography correlated with mini-mental state examination scores in AD patients (Edison 
et al. 2008). Finally, a plethora of studies have reported that antioxidants can counter the 
pro-inflammatory processes of microglia and reduce age-related cognitive impairment 
(Cotman et al. 2002; Crichton et al. 2013; Chaudhari et al. 2014; Huhn et al. 2015; Natrajan 
et al. 2015; Yuan et al. 2016).  
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Common ground in normal cognitive aging and AD 
 Although this review has made a point of distinguishing aging, normal cognitive aging, 
and AD, the pathologies of AD and normal cognitive aging may actually share some 
similarities. In AD, the hallmarks of plaque and tangle accumulation stem from 
inappropriate cleavage of amyloid precursor protein (APP) that eventually results in 
neurodegeneration. Although normal cognitive aging does not have the same 
neurodegeneration, the white matter has an accumulation of damaged myelin. In both 
cases, microglia are known to respond, but are unable to phagocytose the aggregated 
amyloid β and resolve the problem (AD: Hickman et al. 2008; Njie et al. 2012; Krabbe et 
al. 2013; Aging: Safaiyan et al. 2016). Additionally, gene expression of aging and AD 
revealed similar changes to innate immunity (Cribbs et al. 2012).  
Conclusions 
 The traditional focus of aging research on neurodegenerative diseases like AD and the 
associated loss of gray matter neurons has left changes in white matter under studied. Here 
we propose that not only should white matter be a major focus of brain aging studies but it 
may be a critical factor in normal cognitive aging for those who escape AD. In addition, in 
the search for the mechanism of white matter pathology, normal and aberrant neuroimmune 
functions in the brain may be a part of the pathogenic process. 
 We propose that white matter microglia dysfunction drives myelin damage in aging 
and cognitive impairment. In the healthy brain, myelin turnover is dealt with quickly, 
allowing for remyelination and limited appearance of myelin damage. We hypothesize that 
the increased presence of myelin debris with age is indicative of faulty clearance 
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mechanisms due to phagocytic impairment of microglia. As microglia become less 
efficient in phagocytosing myelin, the debris on the myelin sheath or interstitial fluid 
lingers, impairing remyelination. Without resolution, microglia remain chronically 
inflamed, leading to a devastating feed-forward cycle of more myelin damage and more 
inflammation. In this mechanism, microglia are certainly at fault, but there are still many 
gaps left to consider. As such, understanding the complex interplay of microglia and myelin 
may be a key to comprehending our normal aging and provide novel insights to uncover 
new therapies for neurodegenerative dementias.  
 In this dissertation, we will experimentally address some of the questions surrounding 
age-related changes to the white matter and related neuroimmune cells. We will test the 
overall hypothesis that impairments in the clearance of myelin debris in aging is associated 
with cognitive decline. Specifically, we will look to evaluate age-related myelin changes 
at the bright field level, assess related gene expression changes, and determine the efficacy 
of myelin clearance into the cerebrospinal fluid. Next we will determine changes to 
microglial phagocytic activation in the white matter throughout aging and cognitive 
impairment. Finally, we will show that lipofuscin accumulation in the white matter may be 
involved in the age-related myelin pathology and normal cognitive aging. 
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CHAPTER 2: MYELIN DYSFUNCTION 
Introduction 
 Although original findings suggested a loss of neurons was responsible for mild 
cognitive impairment, it is now accepted that there is no neuronal loss with aging in humans 
(Haug et al. 1984; Terry et al. 1987, Freeman et al. 2008) or in monkeys (e.g. Peters et al. 
1998; Merrill et al. 2000). Similarly, quantitative MRI studies have shown that although 
gray matter cortical thickness is reduced (Alexander et al. 2006; Koo et al. 2010), total gray 
matter volume is preserved (Wisco et al. 2008). However, MRI and histological studies in 
both monkeys and humans have reported an age-related loss of white matter volume that 
correlates with cognitive decline (Albert 1993; Tang et al. 1997; Guttmann et al. 1998; 
Peters and Rosene 2003; Wisco et al. 2008). Further, total myelinated fiber length 
decreases by 27%-45% with age (Tang et al. 1997; Marner et al. 2003) and, in addition to 
a loss of myelinated fibers, there is an increase in myelin damage in both aging and 
cognitive impairment (Bowley et al. 2010). 
 The majority of evidence for age-related myelin pathology stems from studies using 
MRI to detect volumetric changes (Guttmann et al. 1998; Wisco et al. 2008), diffusion 
tensor imaging to show loss of myelin integrity (Charlton et al. 2006; Makris et al. 2007; 
Voineskos et al. 2012), electron microscopy to visualize myelin damage and axonal loss 
(Peters et al. 2000; Sandell and Peters 2002; Sandell and Peters 2003; Bowley et al. 2010) 
and biochemical analyses (Hinman et al. 2004; Duce et al. 2006; Hinman et al. 2006; 
Hinman et al. 2008). The imaging techniques require expensive scanning time and 
equipment and electron microscopy relies on specific fixation criteria making none of these 
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techniques useful for archived tissue. However, studying myelination at the light level has 
been met with challenges. Traditional and adapted versions of histological myelin stains 
are effective in measuring areas of total myelin loss (such as seen in models of multiple 
sclerosis), but do not provide the resolution to measure the deep white matter affected by 
normal aging (for examples, see Pistorio et al. 2006; Savaskan et al. 2009). These methods 
are not sensitive enough to measure an approximate 10% myelinated axon loss seen in 
normal aging (Bowley et al. 2010). Spectral Confocal Reflectance (SCoRe) imaging 
detects myelinated axons in fixed tissue using a confocal microscope (Schain et al. 2014) 
and may be useful as a label-free method of visualizing age-related myelination changes in 
the deep white matter.  
 Little is known about the influence of aging on molecular and transcriptional changes 
to the major myelin protein, myelin basic protein (MBP). MBP mRNA is synthesized and 
transported down the peripheral extensions of the oligodendrocyte for translation on-site 
(Ainger et al. 1993; Baron and Hoekstra 2010; Müller et al. 2013). As a protein, MBP is 
found between the intracellular compartments of the myelin sheath, acting as an adhesive 
between the two layers. Without MBP, the intracellular myelin layers pull apart and swell 
(Min et al. 2009). Disrupting MBP, as seen in the shiverer mouse model, leads to 
hypomyelination (Kimura et al. 1989). In MS, myelin basic protein (MBP) can be found in 
the cerebrospinal fluid (CSF; Cohen et al. 1976) and the levels of MBP in the CSF correlate 
with severity of symptoms and lesions diagnosed via MRI (Lamers et al. 1998). Finally, 
treating patients with an immunosuppressant decreases CSF MBP (Romme Christensen et 
al. 2013).  
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We hypothesized that age-related myelin damage would lead to alterations to MBP 
transcription and clearance. First, we sought to determine the effectiveness of SCoRe 
imaging in measuring of demyelination across the lifespan of the rhesus monkey. Next, we 
investigated gene expression changes of MBP from the dorsal prefrontal cortex. Finally, 
with age-related myelin damage, we hypothesized that MBP would be cleared to the CSF. 
To test this, we measured MBP concentrations in the CSF of monkeys across the lifespan 
using ELISA.  
Methods 
Subjects 
 Tissue and cerebrospinal fluid (CSF) were used from 36 rhesus monkeys taken as part 
of an NIA funded Program Project ("Neural Substrates of Cognitive Decline in Aging 
Monkeys", P01-AG000001) and a Research Project ("Histopathology, Neuroimaging and 
Mechanisms of Myelin Damage in Aging Monkey Brain", R01-AG043640). Of the 
monkeys used in this study, 30 were originally obtained from the Yerkes National Primate 
Research Center at Emory University in Atlanta, while 6 animals came from other research 
centers. Prior to selection, health records were screened with strict health criteria to exclude 
any possible confounding clinical diseases or experimental manipulations that could 
impact normal aging by affecting the brain or behavior.  
Behavioral testing 
 Upon entering the study, all monkeys received a battery of behavioral tests that assess 
cognitive functions and have been described in detail elsewhere. The major domains and 
tasks were a test of rule learning using acquisition of the Delayed Non-Match to Sample 
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(DNMS) task, extended delays on DNMS (120 sec and 600 sec) to test recognition 
memory, the Delayed Recognition Span Test (DRST) in both spatial and object modes to 
assess working memory capacity, and the Category Set Shifting Task (CSST) to test 
executive function (Herndon et al. 1997; Moore et al. 2005). Based on a principal 
components analysis (Herndon et al., 1997), a subset of the DNMS and DRST scores were 
identified as the best predictors of cognitive aging and were compiled into a z-score and 
designated the cognitive impairment index (CII). This has proven useful in comparing 
cognitive status with neurobiological endpoints (e.g. Peters, Sethares, & Moss, 1998).  
Brain perfusion for fresh and fixed tissue 
 To harvest fresh tissue for RNA isolation still obtain well-fixed tissue for 
immunohistochemistry, tissue from 10 of the animals was first perfused with 4 liters of 
Krebs buffer at 4°C and is followed by 8 liters of 4% paraformaldehyde at 37°C. With the 
monkey deeply anesthetized, a craniotomy was performed to expose the dura over one 
hemisphere. At the start of Krebs perfusion, the dura was opened and fresh, unfixed biopsy 
samples were removed from area 46 and immediately placed on dry ice and then frozen at 
-80°C for RNA isolation. Once fresh tissue was removed, the perfusate was switched to 
4% paraformaldehyde for 10 minutes. 
 After perfusion, the brain was cryoprotected in buffered glycerol (10% and then 20%) 
with 2% DMSO, and flash frozen at -75°C and stored at -80°C until cut. This method 
completely eliminates freezing artifact as well as the shrinkage produced by sucrose 
cryoprotection (Rosene et al. 1986). One hemisphere was cut in its entirety in the coronal 
plane into 10 interrupted series of 30-micron thick frozen sections so that sections in a 
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series are spaced at 300 micron intervals and collected in buffer with 15% glycerol as 
cryoprotectant and stored frozen at -80°C. Archived tissue was selected for analysis to 
optimize overlap with available fresh-frozen pieces of area 46 and cerebrospinal fluid. 
Once selected, vials of sections are removed from the -80°C freezer, thawed in a 20°C 
water bath and rinsed three times in buffer to remove glycerol cryoprotectant. They are 
then all “batch processed” together as free-floating sections for IHC to ensure that sections 
from all cases are processed in identical reagents under identical conditions and for the 
same time (Giannaris and Rosene 2012; Estrada et al. 2017; Shobin et al. 2017).  
Spectral Confocal Reflectance (SCoRe) imaging 
 SCoRe imaging was used to evaluate age-related changes in myelinated axons (Schain 
et al. 2014). For this, 4% paraformaldehyde fixed, 30µm thick brain sections from 25 
animals were slide mounted and air-dried for 1 hour, coverslipped with Aqua-Mount 
(Thermo Scientific, Waltham, MA) and imaged on a Leica TCS SP8 MP with a 40X/1.3 
oil immersion objective and excited by 488nm, 552nm, and 638nm lasers. Emissions were 
collected at 486nm – 490nm, 559nm – 563nm, and 631nm – 635nm, respectively and the 
genu of the corpus callosum was imaged in 10 z-stacked 0.68 micron images per animal. 
Each image was thresholded and measurements taken for percent area using FIJI software 
(Schindelin et al. 2012). 
Immunohistochemistry 
 Select sections were processed for immunohistochemistry to verify co-labeling of 
SCoRe imaging with axons. Tissue was thoroughly washed and blocked with SuperBlock 
(Thermo Scientific, Waltham, MA) for 1 hour. Next, sections were incubated in primary 
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antibody solution containing mouse anti-hypophosphorylated neurofilament H (NFH; 
Abcam) diluted to 1:1000 with 0.5% SuperBlock and 0.3% Triton X. Sections were 
incubated in primary antibody solution for at 4°C overnight. Tissue was washed very 
thoroughly and placed into secondary antibody solution containing donkey anti-mouse 
Alexa Fluor 647 (Life Technologies, Carlsbad, CA) diluted to 1:500 with 0.5% 
SuperBlock, and 0.3% Triton X for 2 hours. Samples were thoroughly washed, mounted, 
and coverslipped using Aqua-Mount (Thermo Scientific, Waltham, MA). Slides were 
imaged on a confocal microscope at 40X and colabeling with SCoRe was verified by visual 
assessment.  
RNA isolation and qPCR 
 Archived samples from six old (ages 18+) and four young animals (ages 6-9) were used 
for this study. Tissue was removed from the freezer, placed on dry ice, and 100mg pieces 
were excised. On ice, sections were passed through progressively smaller gauged needles 
from 18 to 24 gauge in TRIzol. RNA was extracted according to manufacturer's protocol 
and resuspended in 40µl RNAse-free water. Samples were measured for RNA 
concentration and optical density values at 260/280 using NanoDrop (Thermo Fisher, 
Waltham, MA). RNA was then reverse transcribed (RT) to cDNA using a High Capacity 
RNA-to-cDNA kit (Thermo Scientific, Waltham, MA). Briefly, 2µg of RNA was added to 
10µl RT Buffer Mix 2X, 1µl 20X Enzyme Mix and filled to 20µl with nuclease-free water 
(negative RT controls were created by withholding 20X Enzyme Mix from the sample). 
The reaction mixture was centrifuged briefly to remove any bubbles and incubated in a 
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CFX96 Thermo Cycler (Bio-Rad, Hercules, CA) at 37°C for 1 hour. The reaction was then 
be heated to 95°C for 5 minutes and then held at 4°C.  
 Quantitative Polymerase Chain Reaction (qPCR) was performed using PowerUp 
SYBR Green Master Mix (Thermo Fisher, Waltham, MA). Samples of cDNA (10ng) were 
added to PCR tubes with 10µL SYBR Green Master Mix in triplicate, RNAse-free water 
and 0.2nm of primers designed using Primer-BLAST (National Center for Biotechnology 
Information) for the monkey MBP gene (RefSeq XM_015122215.1): 
Forward: CTCTGGCAAGGACTCACACC 
Reverse: GGTAATGGGGGCAAATGGGA 
These primers amplify a 431-bp fragment of the gene. Primers were also used for the 
housekeeping gene, GAPDH (Sigma Kicqstart Primers). Thermo cycling settings were 
optimized for both sets of primers to be run simultaneously. Briefly, tubes were heated to 
50°C for 2 minutes then further heated to 95°C for 2 minutes. Next, samples were cycled 
40 times through denaturing with heat at 95°C for 15 seconds, annealed at 55°C for 15 
seconds, and extended at 72°C for 30 seconds. As controls, cDNA was run in triplicate 
along with no template controls for each primer. Fluorescent signal was measured at the 
end of each extension step. Cycle threshold (Ct) values were normalized to GADPH to 
determine the relative amount of MBP gene expression using the ΔΔCt method to calculate 
fold change. 
Cerebrospinal fluid collection and Myelin Basic Protein ELISA 
 CSF was collected from the thoracic spine of 23 monkeys prior to euthanasia and 
gravity settled for up to four hours at 4°C. Clear and colorless liquid was removed from 
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the tube and stored in aliquots and frozen at -80°C until use. Samples were rapidly thawed 
immediately prior to use in ELISA assay.  
 To evaluate MBP contents in the CSF, a sandwich-ELISA was used (Ansh labs, 
Webster, TX). Two separate plates were used to evaluate correlations of CSF MBP with 
age and age-related cognitive decline and another plate used to compare CSF MBP and 
DTI data. Each plate was coated with MBP antibody by the manufacturer. A standard curve 
was used in duplicate to allow for detection between 0.3ng/mL and 11ng/mL. Additionally, 
two known MBP controls were also plated in duplicate as positive controls. One hundred 
microliters of CSF from each animal was added in triplicate to individual wells. The 
standards, known positive controls, and CSF samples were incubated on the plate for one 
hour shaking at 800RPM. All liquid was then aspirated and washed with the kit-provided 
washing buffer five times. Each well was then incubated with 100µL of MBP antibody-
biotin conjugate for one hour shaking at 800RPM. The plate was then aspirated and washed 
five times with buffer and then loaded with 100µL of Streptavidin-Enzyme Conjugate-
RTU and incubated for 30 minutes shaking at 800RPM. The plate was again aspirated and 
washed five times with buffer prior to incubation with 100µL 3,3', 5,5;-
tetramethylbenzidine chromogen solution for 10 minutes shaking at 800RPM. The reaction 
was then stopped with manufacturer provided Stopping Solution and the absorbance of 
each well was read using a microplate reader set to 450nm.  
Statistics 
 In assessments of SCoRe and CSF concentrations of MBP, age was considered as a 
continuous variable. Linear regression was used to statistically measure associations with 
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dependent variables over the lifespan. Elderly animals (ages 20+) were separated into 
groups of cognitively spared (CII < 2) and cognitive impaired (CII > 2). Differences 
between groups were assessed using student’s t-test. Alpha was set to 0.05 for all analyses.  
Results 
SCoRe does not effectively reflect age-related myelin damage, but is sensitive to myelin 
changes in cognitive impairment 
 To evaluate myelin damage, we sought to use the recently published method of Spectral 
Confocal Reflectance (SCoRe) imaging (Schain et al. 2014). Example SCoRe images can 
be seen from a young (Figure 2.1A) and an old (Figure 2.1B) monkey corpus callosum and 
verification of co-localization with neurofilament H (NFH) seen in Figure 2.2. We found 
that percent area of SCoRe signal does not significantly correlate with age (F(1,23) = 
0.00852, P = 0.9272, R2 = 0.043, Figure 2.3A). As the three lasers used in this method are 
thought to reflect based on the thickness of myelin surrounding the axon (Schain et al. 
2014), we next separated the signal by laser, but found that there was also no significance 
in the 488nm laser (F(1,23) = 0.091, P = 0.766, R2 = 0.04), the 561nm laser (F(1,23) = 
0.366, P = 0.551, R2 = 0.0345), or the 633nm laser (F(1,23) = 1.583, P = 0.221, R2 = 0.024) 
alone.  
 Next, we separated old animals (ages 20+) into groups of cognitively spared (CII < 2, 
N = 4) and cognitively impaired (CII > 2, N = 9). Cognitively impaired animals had lower 
percent area SCoRe signal than cognitively spared animals (t(11) = 2.538, P = 0.0276, 
Figure 2.3B). This effect was consistent in the 488nm laser (t(11) = 2.216, P = 0.0487) and 
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633nm laser (t(11) = 2.214, P = 0.0489), but there was no statistically significant difference 
found in the 561nm laser (t(11) = 0.933, P = 0.371). 
MBP gene expression is increased in older animals 
 We hypothesized that, in an attempt to correct myelin damage, myelin basic protein 
gene expression would be increased with age. To test this, we used qPCR to compare MBP 
gene expression (normalized to GAPDH expression) in frontal brain tissue from young 
(ages 6-9) and old monkeys (ages 18+). First, we verified that GAPDH Ct was not 
significantly different between young and old animals (t(8) = 0.885, P = 0.201). We 
normalized MBP cycle threshold to GAPDH to get a ΔCt then took the average ΔCt of 
young animals to use as a reference. ΔΔCt was then calculated for each animal in 
comparison to the reference and converted to fold change (2^-(ΔΔCt )). To compute the 
average fold change, we normalized the young animals by dividing 1 by the average of the 
individual fold change values from young animals to get a normalization factor (0.6769). 
Individual fold change values were normalized, averaged and correlated with age to find 
that MBP gene expression increases with age (F(1,8) = 15.4, P < 0.004, R2 = 0.616). Taking 
the average fold change for old animals, we found that MBP gene expression increased 
9.35 fold in old animals compared to young animals.  
The concentration of Myelin Basic Protein increases in the CSF is dependent on age and 
cognitive impairment 
 To test the hypothesis that age-related myelin breakdown in the brain would result in 
the clearance of myelin in the CSF, MBP was measured in the CSF of 23 behaviorally 
tested rhesus monkeys across the age spectrum (7.6 to 27.8 years) using sandwich ELISA. 
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As expected, increased concentration of MBP in the CSF was predicted by age (F(2,20) = 
7.102, p < 0.005). Approximately 28.96% of the variance in the concentration of MBP in 
the CSF was explained by age (Figure 2.5A). Although young (ages 5-9) and middle-aged 
animals (ages 10-19) tend to have low variance in their cognitive abilities, old animals 
(ages 20+) have a wide range of cognitive abilities. Additionally, myelin degeneration 
increases not only with age, but also cognitive impairment (Bowley et al. 2010). Thus, old 
animals were stratified based on their cognitive functions into cognitively spared (CII < 2) 
and cognitively impaired (CII > 2). It was expected that since cognitively impaired animals 
have the greatest myelin degeneration those animals would have the greatest amount of 
myelin cleared to the CSF. However, our results indicated that the concentration of MBP 
in the CSF of old cognitively impaired animals is significantly less than the concentration 
of MBP in the CSF of old spared animals (t(10) = -5.064, P < 0.0005, Figure 2.5B). 
 Finally, we correlated SCoRe signal with the concentration of MBP in the CSF in 
animals that were used in both experiments. Across all animals, there was no correlation 
between the concentration of CSF MBP and SCoRe signal in the corpus callosum (F(1,19) 
= 0.511, P = 0.484, R2 = 0.025, Figure 2.5C). However, when looking at the old animals 
only (ages 20+), there was a significant direct correlation between the concentration of 
MBP in the CSF and SCoRe signal (F(1,9) = 6.803, P = 0.0284, R2 = 0.367, Figure 2.5D).  
Discussion 
 
Summary 
 In this paper, we investigated age-related changes to myelin using multiple methods. 
First, we used a label-free technique for myelin visualization, spectral confocal reflectance 
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(SCoRe) imaging. Although SCoRe was not able to detect known age-related changes to 
myelin, we found significant a significant decrease in the area occupied by SCoRe label in 
old cognitively impaired animals. Next, we used RT qPCR to find an age-related increase 
in MBP gene expression. Finally, we investigated clearance of MBP into the CSF using 
ELISA. We found that the concentration of MBP in the CSF increased with age. 
Interestingly, in old animals, cognitively impaired animals had a decrease in MBP 
concentration in the CSF compared to cognitively spared animals. 
SCoRe and myelin visualization 
 A vast amount of research from our lab and others has shown that myelin damage 
occurs with age, resulting in notable myelin defects (Bowley et al. 2010) and a loss of 
myelinated axons (Sandell and Peters 2002; Sandell and Peters 2003). Traditionally, age-
related changes to myelination have been investigated through overall white matter 
changes with structural MRI or at the ultrastructural level with electron microscopy. 
Although these methods often great insight, each has methodological drawbacks that make 
them unusable in the current study.   
 While large-scale imaging methods do not directly measure myelin, MRI can be used 
to give a broad overview of white matter quality and volume that generally decrease with 
age (Guttmann et al. 1998; Wisco et al. 2008). Outside of a decrease in white matter volume 
with age, researchers focused on white matter hyperintensities, age-related lesions that 
could be visualized via MRI and correlated with cognitive decline (De Groot et al. 2000; 
de Leeuw et al. 2001; Prins and Scheltens 2015). Recent advances in tractography imaging 
have made white matter study more accessible. Diffusion tensor imaging (DTI) uses a 
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measure of fractional anisotropy (FA) to measure what is thought to be myelin integrity 
(Moseley 2002; Sullivan and Pfefferbaum 2006; Chang et al. 2017). With this, DTI 
measures of FA have been found to decrease in correlation with age in both humans 
(Charlton et al. 2006; Voineskos et al. 2012) and monkeys (Makris et al. 2007). While these 
scans would be useful measures of general myelin integrity, they were not obtained for the 
majority of animals with available tissue for the current studies.  
 Using electron microscopy (EM), sections can be visualized at the ultrastructural level 
to quantify changes in the number of myelinated axons as well as visualize defects in 
myelination that may not be apparent at the light microscopic level (Bowley et al. 2010). 
However, doing EM requires sections to be fixed in a specific manner as to not disturb the 
tissue quality that makes the archived monkey tissue available for the current studies 
unsuitable for EM processing. 
 Finding an effective measurement technique to visualize myelin in the usable for this 
study has thus been difficult. In extreme cases of myelin damage, such as models of 
multiple sclerosis, histological markers of lipid content (luxol fast blue or eriochrome 
cyanine) are enough to distinguish lesioned regions. However, these stains are not sensitive 
enough to distinguish the subtle myelin changes in aging and do not allow for direct 
visualization of myelinated sheaths. In immunohistochemical stains, antibodies raised 
against MBP are often used to visualize myelination at the light level. In our studies, we 
found that immunostaining MBP was clear in the superficial white matter, but MBP 
staining could not penetrate the deep white matter, potentially due to fat content. 
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Additionally, immunohistochemistry relies on the labeling of a specific protein that may 
be changed under the conditions of aging. 
 Therefore, we sought a label-free method that would allow myelin visualization and 
quantification at the light level, while not being limited to a specific protein or the 
superficial white matter. This technique was first reported by Schain and colleagues (2014) 
as a method to visualize myelinated axons. These researchers hypothesized that SCoRe 
occurred due to thin film interference, where the laser light is reflected off each layer of 
myelin, causing interference and allowing for visualization.  
 In this study, we hypothesized that SCoRe would decrease with age in the corpus 
callosum due to myelin pathology. However, we found no correlation between age and the 
area occupied by SCoRe signal. Interestingly, there was a significant decrease found the 
density of SCoRe-imaged myelinated axons in cognitively impaired aged animals 
compared to cognitively spared aged animals. These findings contradict previous work 
using electron microscopy and diffusion imaging. Indeed, Bowley et al (2010) reported a 
20% decrease in myelinated axons with age. This discrepancy across methods raise the 
possibilities that 1) SCoRe lacks the sensitivity to identify age-related myelin damage, but 
can detect structural differences in myelin that occur with cognitive impairment, when 
myelin damage is known to be more severe (Bowley et al 2010) or 2) SCoRe images only 
a subset of myelinated axons that are not affected in aging but are affected in cognitive 
decline, 3) Fiber bundle orientation and clustering, and properties of myelin constituents, 
which are distinct across white matter regions in the monkey, produce inherent variability 
in SCoRe imaging. We believe the findings in this paper are a result of a combination of 
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these factors. Because of the density of myelin in the corpus callosum, it is possible that 
reflection is interference between reflected light occurs from more than a single myelinated 
axon. In our study and in Schain et al (2014), corpus callosum visualization is not as clear 
as in peripheral nerves or less myelinated structures such as the superficial white matter. 
Because of the inability to consistently and clearly detect individual myelin fibers, rather 
than general bundles of myelinated axons, SCoRe in the corpus callosum may not be 
suitable to detect age-related myelin loss. 
 Therefore, the decrease in SCoRe signal in cognitive impairment is not likely 
demonstrative of a loss or thinning of myelin, but a change in quality of myelin. Schain 
and colleagues (2014) showed that Schmidt-Lanterman incisures were detectable by 
SCoRe, likely due to the differences in reflection caused by the cellular contents. We 
hypothesize that changes to protein and/or lipid content of myelin in cognitively impaired 
animals causes the differences seen in SCoRe signal. Although many studies have 
investigated age-related changes to myelin structure, few have looked at the molecular 
content of myelin and none have determined differences in age-related cognitive decline. 
Previous studies have reported that myelin basic protein content decreases with age (Ansari 
and Loch 1975; Xing et al. 2012) and age-related ubiquitination of 2’3’-cyclic nucleotide 
3’-phosphodiesterase (Hinman et al. 2008), suggesting myelin protein content changes 
occur with age. Therefore, it is not difficult to imagine changes to the lipid protein content 
of myelin that could result it altered reflection from SCoRe. EM studies or biochemical 
analysis of myelin content would aid in our understanding of changes to myelination with 
age and cognitive impairment and provide a better understanding of the SCoRe signal.  
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Expression of MBP and myelin damage 
 As previously mentioned, total MBP content was found to decrease with age (Ansari 
and Loch 1975; Xing et al. 2012) in addition to myelin loss and damage (Bowley et al. 
2010). We hypothesized that age-related myelin damage would result in increased coping 
mechanisms, such as an increase in MBP gene expression. As expected, our results 
indicated a 9.35 fold increase in MBP gene expression in dorsal prefrontal cortex with age. 
Besides our proposal of increased MBP expression as a mechanism to repair myelin 
damage, we propose a few alternatives based on MBP trafficking and myelin formation.  
 As mentioned earlier, mRNA synthesis of MBP occurs in the oligodendrocyte and is 
transported in a vesicle for on-site translation (Ainger et al. 1993; Baron and Hoekstra 
2010; Müller et al. 2013). In this process, mRNA production, trafficking, or translation 
could be improperly functioning with age, causing myelin damage. Our results demonstrate 
that production of MBP mRNA is occurring robustly, and is actually increased with age 
and therefore unlikely to be the fault in this mechanism. During stress, RNA binding 
proteins may sequester non-essential RNAs into stress granules to ensure cell survival 
(Vanderweyde et al. 2013). It is possible that stress on oligodendrocytes causes 
sequestration of myelin-related mRNA leading to myelin destabilization and damage. In 
situ studies to determine localization of myelin mRNA and protein studies to ensure proper 
translation are necessary to determine if the process of myelin damage involves mRNA. 
Clearance of myelin throughout aging and cognitive decline 
 The major pathology of aging and age-related cognitive decline is myelin damage. In 
multiple sclerosis, myelin debris clearance occurs and MBP is removed into the CSF in a 
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manner that correlates with myelin damage (Lamers et al. 1998). We hypothesized that 
increased myelin damage in aging would lead to clearance of myelin proteins to the CSF. 
In accorance with our hypothesis, we reported a significant age-related increase in the 
concentration of MBP in the CSF in rhesus monkeys. However, despite cognitive 
impairment correlating with an increase in myelin damamge (Bowley et al. 2010), the 
concentration of MBP in the CSF is significantly lower in cognitively impaired compared 
to cognitively spared aged monkeys. These results suggest a dysfunction of myelin 
clearance that separates old monkeys based on cognitive abilities.  
 Two major mechanisms of debris clearance in the brain are phagocytosis via microglia 
and glymphatic clearance from the interstitial fluid. Myelin debris clearance is imperitive 
to homeostasis as myelin debris can inhibit oligodendrocyte differentiation and 
remyelination (Miron et al. 2013; Lampron et al. 2015). Microglia, however, can become 
overburdened by age-related myelin damage and unable to sufficiently phagocytose the 
debris (Safaiyan et al. 2016). As myelin damage accrues and microglia are unable to 
account for debris degradation, myelin fragments may accumulate in the interstitial fluid. 
Recently described, the glymphatic system is a paravascular pathway that drives flow and 
debris clearance between the interstitial fluid (ISF) and the CSF (Iliff et al. 2012). As 
microglia leave more myelin debris to linger in the ISF, fluid exchange between ISF and 
CSF would clear the debris to the CSF, as we see with normal aging. However, like the 
phagocytic system, evidence suggests an age-related decrease in efficiency and flow of the 
glymphatics (Kress et al. 2014). Future studies evaluating glymphatic efficiency in 
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conjunction with phagocytic assays are needed to determine the role of each system in 
cognitive decline. 
Conclusions 
 In this paper, we investigated age-related changes to myelin and a major constituent of 
myelin, myelin basic protein. We propose an age-related failure in both phagocytosis and 
glymphatic clearance of myelin. In normal aging without cognitive impairment, we 
hypothesize that a decrease in phagocytic function leads to an over-reliance on the 
glymphatics for debris clearance resulting in an age-related increase in myelin debris in the 
CSF. However, in cognitive impairment, the inefficiencies of both systems take their toll, 
leading to an accumulation of myelin debris in the ISF (and little myelin in the CSF) and 
inhibition of remyelination. In both situations, the increase in myelin debris causes an 
unexpected inhibition in new myelination, leaving oligodendrocytes with increased myelin 
protein mRNA that cannot be readily used, however further research is needed to provide 
a more concrete causal connection between these mechanisms. Regardless, our research 
provides novel insight into the dysfunction of clearance mechanisms in aging and cognitive 
decline. We suggest these systems as potential targets for therapies to prevent age-related 
cognitive decline and possibly age-related neurodegenerative disease. 
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Figure 2.1. Example SCoRe imaging in the corpus callosum. Spectral Confocal 
Reflectance (SCoRe) imaging is a label free method of collecting reflected light to image 
myelinated axons using three lasers from a confocal microscope (Schain et al. 2014). We 
used SCoRe imaging in the corpus callosum of rhesus monkeys to evaluate the ability of 
this method to detect age-related myelin pathology (Peters and Rosene, 2003). Example 
images of one optical slice from A) a young monkey (age 9.5) and B) an old monkey (age 
25.4). Scale bar = 20µm 
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Figure 2.2. SCoRe colocalizes with axons. A) Spectral Confocal Reflectance (SCoRe, 
green) signal was collected on tissue also immuno-stained with B) neurofilament H (NFH, 
magenta) in the white/gray boundary of frontal white matter to verify the C) co-localization 
of SCoRe signal with axons (white). Yellow arrows point out a selection of the double 
labeled axons and the blue arrow points to an axon with no SCoRe signal. Scale bar = 20um 
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Figure 2.3. SCoRe imaging quantification in aging and cognitive impairment. We 
tested if Spectral Confocal Reflectance (SCoRe) imaging is able to detect age-related 
myelin pathology in the rhesus monkey corpus callosum. For each animal, 10 z-stack 
images were taken from the corpus callosum and quantified for percent area of SCoRe 
signal collected. A) The percent area of reflectance signal collected by SCoRe did not 
correlate with rhesus monkey age as shown by scatterplot, where each point represents data 
from a single monkey. Behavioral data from each monkey was compiled into a z-score 
known as the Cognitive Impairment Index (CII). To assess if SCoRe could detect myelin 
pathology in age-related cognitive decline, old monkeys (ages 20+) were separated into 
groups of cognitively spared (CII < 2) and cognitively impaired (CII > 2). B) Vertical 
scatter plot showing individual data from each animal (open circles) and mean data (black 
line). We found that cognitively impaired monkeys had significantly less percent area 
occupied by SCoRe signal than cognitively spared monkeys, suggesting that SCoRe can 
detect the myelin pathology separating these groups. *P < 0.05 
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Figure 2.4. Gene expression of MBP in the dorsal prefrontal cortex. RNA was isolated 
from area 46 of 4 young (ages 6-9) and 6 old monkeys (ages 18+) and reverse transcribed 
to cDNA. We performed qPCR on MBP and GAPDH and normalized MBP cycle threshold 
to GAPDH (ΔCt) then took the average ΔCt of young animals to use as a reference. ΔΔCt 
was calculated for each animal in comparison to the reference and converted to fold change 
(2^-(ΔΔCt )). To compute the average fold change, we normalized the young animals by 
dividing 1 by the average of the individual fold change values from young animals to get 
a normalization factor (0.6769). Individual fold change values were normalized and 
averaged. As shown above, normalized fold change values are represented as black 
diamonds and the fold change of 1 (average of the young animals) is presented as a dashed 
line. We found that MBP gene expression increased significantly with age as tested by 
linear regression (P < 0.005). 
  
35 
 
Figure 2.5. The concentration of MBP in the CSF in aging and cognitive decline. We 
used an ELISA for myelin basic protein (MBP) and cerebrospinal fluid (CSF) taken from 
monkeys across the rhesus monkey lifespan. A) Scatter plot and linear regression shows 
that the concentration of MBP in the CSF correlates with age. As myelin pathology 
increases with age (Bowley et al. 2010), our results suggest that myelin proteins are cleared 
to the CSF. B) To assess the impact of age-related cognitive impairment on the 
concentration of MBP in the CSF, old monkeys (ages 20+) were stratified into groups of 
cognitively spared (CII < 2) and cognitively impaired (CII > 2). Open circles represent 
individual data from each animal, black bars represent average per group. The 
concentration of MBP in CSF was significantly greater in the spared animals compared to 
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the impaired. These results suggest a potential defect in the clearance of myelin proteins to 
the CSF in cognitively impaired animals. This defect may be hindering remyelination by 
causing damaged myelin to linger. C) Scatter plots and linear regression of MBP 
concentration in CSF against SCoRe signal. We found that SCoRe signal did not correlate 
with monkey age. D) However, in old animals (ages 20+), SCoRe signal percent area was 
significantly related to the concentration of MBP in the CSF. This suggests that clearance 
of myelin protein to the CSF is necessary to maintain myelin in old animals. 
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CHAPTER 3: MICROGLIAL ACTIVATION AND PHAGOCYTOSIS 
This chapter has been previously published and has been reproduced here with minor 
alterations and permission from all authors and appears in: 
Shobin et al. (2017) Microglia activation and phagocytosis: relationship with aging and 
cognitive impairment in the rhesus monkey. Geroscience, 39(2): 199-220 
Introduction 
 Although general changes in microglia activation have been widely studied, the phagocytic 
capacity of these cells in aging and cognitive decline is not as well understood. Studies on 
peripheral immunity have shown a loss of phagocytic capacity and function in macrophages 
with age (Plowden, et al., 2004), although this result is not consistent across all studies (Gardner 
et al. 1981) and may differ between inflammatory cell types (Linehan et al., 2014). Cultured 
macrophages from aged humans have a diminished phagocytic capacity for myelin debris 
(Natrajan et al. 2015) and in vivo studies have shown the rate of remyelination is reduced in 
aged rodents but can be restored with an infusion of monocytes from young animals (Ruckh et 
al. 2012). Finally, phagocytic activation of microglia and size of microglial lysosomes 
increases with age in addition to an increase in microglia adjacent to and contacting myelin 
(Safaiyan et al. 2016). While these data suggest that phagocytic capacity of old macrophages 
is impaired, the reason for this functional decline is unknown. Additionally, no study has 
investigated whether phagocytic activation in the aging brain is related to cognitive decline. 
 The current study using brain samples from behaviorally characterized rhesus monkeys 
was designed to assess the relationship between microglial activation and phagocytic 
phenotype and their associations with age-related cognitive decline. To do so, we use Galectin-
3 (Gal-3) antibody as a marker for phagocytic activation. Gal-3 (also known as Mac-2) is a 
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conserved lectin involved in cell adhesion and phagocytosis in macrophages (Dumic, Dabelic, 
& Flögel, 2006). Gal-3 is expressed ubiquitously throughout the cell, cell surface, and 
extracellular space and contains a C-terminal carbohydrate recognition binding domain 
important for cell adhesion and phagocytosis (Pugliese et al., 2015). Gal-3 is selectively up-
regulated in phagocytic macrophages (Elliott et al. 1991) and transgenic mice deficient in Gal-
3 have reduced phagocytic ability (Sano et al. 2003). Gal-3 also is necessary for the the 
microglial response to myelin degeneration (Hoyos et al. 2014). Additionally, we used the LN3 
antibody which recognizes the HLA-DR major histocompatability complex class II receptor 
to mark activated macrophages that could be either pro- or anti-inflammatory (Conde and 
Streit, 2006). We also used double label immunofluorescence to determine if the phagocytic 
priming of activated microglia changes with age or is associated with cognitive decline. The 
overall goal was to test the hypothesis that dysfunctional age-related phagocytic activation in 
the brain of behaviorally tested rhesus monkeys is related to microglial activation and cognitive 
impairment. 
Materials and Methods 
Subjects 
 Brain tissue from 44 rhesus monkeys was used in this study. This tissue had been 
collected and stored as part of an NIA funded Program Project ("Neural Substrates of 
Cognitive Decline in Aging Monkeys", P01-AG000001) and a Research Project 
("Histopathology, Neuroimaging and Mechanisms of Myelin Damage in Aging Monkey 
Brain", R01-AG043640). Of the monkeys used in this study, 38 were originally obtained 
from the Yerkes National Primate Research Center at Emory University in Atlanta, while 
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6 animals came from other research centers (see Table 3.X). Prior to selection, health 
records were screened with strict health criteria to exclude any possible confounding 
clinical diseases or experimental manipulations that could impact normal aging by 
affecting the brain or behavior.  
 Based on tissue availability, monkeys were divided between experiments for activated 
microglia using LN3 (N=19) and phagocytic microglia using Gal-3 (N=30). Six monkeys 
overlapped between studies (see Table 3.X). Prior studies of rhesus monkey survival and 
of cognitive decline suggest that, relative to humans, the rhesus monkey ages at an 
approximate ratio of 1 year for every 3 human years (Tigges et al., 1988). As such, animals 
for each experiment were divided into groups of young adult (ages 5.0 - 9.9 at euthanasia), 
middle-aged (ages 10.0 -19.9 at euthanasia) and old (ages 20+ at euthanasia). While the 
young and old groups have a relative balance of males and females, there were insufficient 
males to balance the middle-aged subject group in each experiment. Although stratifying 
animals by age range allows for easy classification of each animal, in statistical analyses, 
age was also used as a continuous variable in regression analyses to identify changes that 
occur across the lifespan.  
Behavioral testing 
 Upon entering the study, all monkeys received a battery of behavioral tests that took 
place over a three to six month period and was completed approximately one to two months 
before euthanasia. These tests assess a variety of cognitive domains. Acquisition of the 
Delayed Non-Match to Sample (DNMS) task is a measure of rule learning. Assessment of 
extended delays on DNMS (120 sec and 600 sec) test recognition memory. The Delayed 
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Recognition Span Task (DRST) assesses working memory capacity in both spatial and 
object modalities. Finally the Category Set Shifting Task (CSST) assesses executive 
function including set shifting. Details of these tasks can be found elsewhere (Herndon et 
al. 1997; Moore et al. 2005). 
 Initial inspection of how these tests compared to our measures of microglial reactivity 
indicated associations with measures of DNMS and DRST but not with CSST measure. 
Interestingly, a principal components analysis (Herndon et al., 1997), had demonstrated 
that a subset of DNMS and DRST measures were the best predictors of cognitive aging. 
These have been compiled into a z-score which is designated the cognitive impairment 
index (CII) and has proven useful in comparing cognitive status with a variety of 
neurobiological endpoints (e.g. Peters, Sethares, & Moss, 1998). To avoid multiple 
comparison problems the CII was used in all comparisons in this study.  
Age and cognitive impairment across experiments 
 Subjects from each experimental cohort were compared to ensure similarities between 
groups. As age is normally a predictor for cognitive impairment, the entire cohort (N=44) 
was first analyzed using regression analysis and results showed that increases in age 
significantly predicted increases in CII in this cohort (F(1,41) = 16.19, p < 0.0005, R2 = 
0.266). As shown in Figure 3.6, linear regression demonstrated a significant direct 
relationship between age and CII in each of the subsets of subjects used for Gal-3 studies 
(F(1,27) = 13.10, p < 0.001, R2 = 0.320, Figure 3.6A) and LN3 studies (F(1,16) = 5.98, p 
< 0.05, R2 = 0.227, Figure 3.6B). As one subject (AM121) with a very large CII appeared 
to drive the correlation between CII and age in the LN3 cohort, the CII of the LN3 subjects 
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were tested for outliers using a multiple of 1.5 times the interquartile range to determine a 
cutoff of CII score 6.32. Thus, AM121 (CII score of 12.37) was removed and the regression 
still demonstrated that age predicted CII (F(1,15) = 6.41, p < 0.05, R2 = 0.253). As the 
inclusion of AM121 did not impact the significance of the correlation between age and CII 
score, this animal was included in all analyses unless otherwise stated. 
Brain perfusion and tissue section preparation and storage 
 Approximately one to two months after the conclusion of behavioral testing, monkeys 
were deeply anesthetized with sodium pentobarbital and perfused transcardially through 
the aorta with Krebs Henseleit buffer, pH 7.4 at 4°C for five minutes while fresh tissue 
samples were harvested. This was followed immediately by perfusion with 4% buffered 
paraformaldehyde (pH 7.4, 37°C) for 10 minutes. Immediately following perfusion, the 
brain was blocked, in situ, in the coronal stereotactic plane, removed from the skull and 
placed in the same paraformaldehyde fixative overnight at 4°C. It was then cryoprotected 
by successive incubations in 0.1M phosphate buffer containing first 10% glycerol with 2% 
DMSO and then buffer with 20% glycerol and 2% DMSO until the brain equilibrated 
(Rosene et al. 1986). It then was flash frozen in isopentane at -75°C after which it was 
stored at -80°C until it was cut on a freezing microtome into 10 interrupted series of 30 µm 
thick sections. Sections were collected in buffer with 15% glycerol as a cryoprotectant, 
equilibrated overnight at 4°C and then frozen and stored at -80°C until removed and thawed 
for immunohistochemistry.  
Immunohistochemistry 
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 To eliminate confounds in processing, sections for all subjects to be stained with an 
antibody were removed from -80°C storage at the same time, rapidly thawed to room 
temperature and "batch processed" together in the same reagents for the same time to 
facilitate quantitative analyses across subjects. For LN3 staining, 6-10 sections per animal 
were stained at section intervals of approximately 1200 µm. For Gal-3 staining, 4-7 
sections per animal were stained at sections intervals of approximately 2400 µm. Once 
thawed, sections were washed 3 times in 0.05M Tris buffered saline (TBS, pH 7.6) to 
remove the glycerol. Immunohistochemistry protocols were optimized as described by 
Hoffman et al. (2008). To break cross-links formed during fixation, antigen retrieval was 
performed by incubating the sections in 10mM citrate buffer (pH 6.0) in a microwave tissue 
processor (PELCO Biowave, Ted Pella, Inc., Redding, CA) for 5 minutes at 550W and 
40°C followed by incubation in the same buffer at room temperature for 1 hour on a rocking 
platform. Sections were again washed in TBS (3 x 5 minutes), then incubated with 3% 
buffered hydrogen peroxide for 30 minutes to quench endogenous peroxidases. Next, tissue 
was washed with TBS (3 x 5 minutes) and blocked with SuperBlock (Life Technologies, 
Grand Island, NY) or 10% normal goat serum in TBS (LN3 tissue only) for 1 hour. Primary 
antibodies were diluted 1:700 (mouse IgG1 anti-Gal-3, Abcam, Cambridge, MA) or 1:10 
(mouse IgG2b anti-LN3, MP Biomedicals, Santa Ana, CA) in TBS containing 0.5% 
SuperBlock (or 2% normal goat serum for LN3 tissue) and 0.3% Triton-X. As a control, a 
few sections from various animals were placed in carrier solution (TBS containing 0.5% 
SuperBlock/2% normal goat serum and 0.3% Triton-X) but omitting primary antibody. For 
tissue in Gal-3 primary antibody, sections were microwaved in primary antibody or carrier 
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solution for 5 minutes at 250W and 30°C. In both experiments, incubation in primary then 
proceeded on a rocking platform at 4°C for 40 hours.  
 After the primary antibody incubation, tissue was washed with TBS (3 x 5 minutes) 
and incubated for one hour in secondary antibody containing goat anti-mouse (Vector 
Laboratories, Burlingame, CA) diluted 1:600 in buffer containing 0.5% SuperBlock/2% 
normal goat serum and 0.3% Triton-X. Tissue labeled with Gal-3 was also microwaved for 
5 minutes at 250W and 30°C in secondary antibody. Following the secondary antibody 
incubation, tissue was washed with TBS (3 x 5 minutes) and incubated with avidin biotin 
complex using Vectastain ABC kit (Vector Laboratories, Burlingame CA) for 1 hour. 
Tissue was washed with TBS (3 x 5 minutes), then exposed to a chromogen solution 
containing 0.5mM 3-3 diaminobenzidine (Sigma-Aldrich, St. Louis, MO) and 0.03% 
hydrogen peroxide in TBS for 10 minutes. Tissue was then washed with TBS (3 x 3 
minutes), mounted on gelatin coated slides, and dried overnight. For Gal-3 stained tissue, 
slides were lightly counterstained in 0.5% thionin (pH 4.8) for 30 seconds. All slides were 
then dehydrated through graded alcohols (0%, 50%, 75%, 95%, 100%, 100%, 3 minute 
each), and cleared in xylenes (2 x 5 minutes). Slides were coverslipped with Permount 
(Fisher Scientific, Waltham, MA). 
Regions of interest 
 Regions of interest (ROI) were identified using a 2X objective and boundaries outlined 
according to the criteria illustrated in Figure 3.7. 
 Cingulum Bundle (Figure 3.7A-D): The cingulum bundle (CGB) was defined as a semi-
triangular white matter region within the cingulate gyrus. For the Gal-3 experiments and 
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the rostral sections in the LN3 experiments, the CGB was bounded ventrally by the CC. 
The caudal portions of the CGB used in the LN3 experiments are bounded by the cingulate 
gyrus gray matter and an arbitrary line connecting area 29a-c to the junction of area 31 and 
the parietal area PE cingulate.  
 Corpus Callosum (Genu, Figure 3.7A, B): For the genu of corpus callosum (CC), LN3 
cell counting was bounded slightly more medially than that of Gal-3 counting, thus the 
entirety of the CC defined in the LN3 experiment was contained in the CC defined in the 
Gal-3 experiment. For the LN3 experiment, the anterior edge of the CC was identified in 
the first serial section containing callosal fibers from the midline. For Gal-3 experiments, 
the most rostral section was identified as the first section containing both CC and internal 
capsule. The posterior end of the genu for both experiments was identified when the septum 
pellucidum first appears as it separates the anterior body from the rostrum. The 
dorsomedial boundary of the genu is the indusium griseum or the lateral ventricle (once 
the caudate is present) and the dorsolateral boundary is the anterior cingulate gyrus. For 
LN3 sampling, the lateral boundary of the genu is defined as a straight line connecting the 
medial edge of the gray/white boundary of the anterior cingulate to the lateral edge of the 
indusium griseum or the lateral edge of the lateral ventricle (once the caudate is present). 
For Gal-3 experiments, the lateral boundary of the CC extended from the lateral edge of 
the lateral ventricle to the ventrolateral edge of the cingulum bundle as to not overlap with 
the CGB or the FWM. 
 Frontal White Matter (Figure 3.7A, B): For both experiments, the frontal white matter 
(FWM) was defined as the white matter region excluding corpus callosum and cingulum 
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bundle starting from the lateral most junction of the CC and caudate nucleus, ventral lateral 
across the putamen, then ventral to the intersection of the putamen and the claustrum and 
dorsal to the white matter beneath the inferior arcuate sulcus. The FWM then follows the 
border of the gray matter around to where it began.  
Unbiased stereology 
 Standard unbiased stereology was performed on blind coded sections using a Nikon 
E600 light microscope equipped with a Q-Imaging digital camera, a motorized stage and 
Stereo Investigator software (MBF Bioscience, Williston, VT). Gal-3 and LN3 positive 
cells were identified using the soma as the counting target and numbers estimated using 
the optical fractionator method as described by West, Slomianka, & Gundersen, 1991. For 
each ROI and marker, pilot studies were performed to determine appropriately sized 
sampling grids and counting frames. For Gal-3 stained tissue, 4-7 sections were used for 
each animal. Sections were blind coded and counted using a 20X/0.50 objective lens within 
a counting frame of 99.0 X 66.6 X 10 µm3 with the dissector top and bottom guard volume 
extending 5 µm below the z extent of the counting brick. For LN3 stained tissue, 6-10 
sections were blind coded and counted using a 60X/1.40 oil-immersion objective lens 
within a counting frame of 60 X 60 X 5 µm3 with the dissector top and bottom guard 
volume extending 1 µm below z extent of the counting brick.  
 The sampling grid was randomly placed over the outlined ROI prior to counting. Cells 
were considered to be Gal-3 or LN3 positive if they contained dark brown staining of a 
small cell body and at least one process or an enlarged circular cell body alone. The cell 
body was used as the counting object for cells that fell within the dissector or across its 
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inclusion planes. The Cavalieri estimator was used to estimate volumes and the coefficient 
of errors (CE) was calculated as described by Gundersen et al. (1999). With the counting 
frame and sampling grid used in the current study, a minimum of 100 cells for each region 
and animal and were counted and the CE was 0.1 or less to ensure minimal variance due 
to sampling. Due to the low number of Gal-3 positive cells in young and middle-aged 
animals, CE values below 0.1 were unattainable making stereological estimations of total 
cell counts difficult. Therefore, cell density reported in mm3 was used to compare relative 
counts between subjects. 
Morphology 
 In old animals (ages 20+), subtypes of Gal-3 positive cells were identified and counted 
according to the morphological criteria as ramified, hypertrophic, or amoeboid (see Figure 
3.8) as defined by Karperien et al. (2013). As shown in Figure 3.8, cells were counted as 
ramified if they had one or more thin process extending from a small, dense cell body. 
Amoeboid cells were identified if they had enlarged, semi-circular cell bodies with limited 
to no processes extending from the soma. Hypertrophic cells were identified if they had 
any of the following: 1) a semi-circular or rod-like cell body with no processes, 2) an 
enlarged, non-circular cell body with at least one process, or 3) an enlarged, non-circular 
cell body with dark, dense, and thicker processes. 
Immunofluorescence Co-localization and Quantification 
 For double label immunofluorescence of activated microglia (LN3+) and the 
phagocytic phenotype (Gal-3+), two sections containing FWM from each of nineteen 
animals were stained using mouse IgG2b anti-LN3 and mouse IgG1 anti-Gal-3. Sections 
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were thawed together and first washed with buffer to remove the glycerol and then 
incubated in SuperBlock for 1 hour, and placed in 0.5% SuperBlock, 0.3% Triton-X 
solution containing LN3 (1:62.5) and Gal-3 (1:150) overnight at room temperature. As 
negative controls, sections were either incubated in carrier solution, carrier solution 
containing Gal-3, or carrier solution containing LN3. Following primary antibody 
incubation, tissue was washed with TBS then incubated in secondary antibody solution 
containing 0.5% SuperBlock, 0.3% Triton X, AlexaFluor 488 goat anti-mouse IgG2b 
(1:1000, Invitrogen, Carlsbad, CA) and AlexaFluor 568 goat anti-mouse IgG1a (1:1000, 
Invitrogen, Carlsbad, CA). Sections were then washed and mounted. Once semi-dry, the 
slides were rehydrated in buffer for 5 minutes, then dehydrated in 70% ethanol for 5 
minutes and incubated with Autofluorescence Eliminator Reagent (Millipore, Darmstadt, 
Germany) for 45 seconds. The slides were cleared with 70% ethanol (3 x 1 minute) and 
coverslipped using anti-fading mounting medium (PVA-DABCO, Sigma-Aldrich, St. 
Louis, MO).  
 Co-localization of Gal-3 and LN3 was determined in the FWM of young and old 
animals using a Leica TCS SPE laser scanning confocal microscope (Buffalo Grove, IL). 
AlexaFluor-488 emission was detected using argon laser excitation at 488nm whereas 
Alexafluor-568 emission was detected using 561nm laser excitation. To ensure equal 
counting between animals, exhaustive searches were first performed for the less dense Gal-
3 labeled cells in young animals. Pre-scanning determined that twenty-five z-stack images 
could be taken per animal with at least 1 Gal-3 positive cell per image identified with a 
40X objective lens. The width of the image was determined by the point where no Gal-3 
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positive staining was visualized. The number of z-slices were determined using the 
automated system optimized settings. LN3 was visualized in green and Gal-3 in magenta. 
Cells in each image were counted as single labeled Gal-3 (magenta only in a cell body with 
at least one process) or Gal-3 double labeled with LN3 (white image of double-labeled cell 
body with at least one process). Double labeled cells were further subdivided into two 
categories: 1) overlapping double label (white staining verified as double labeling by 
investigation of individual color channels) and balloon double label (magenta “ballooned” 
white or magenta process extending from a cell body encircled by green label). 
 Z-stack images contained in .LIF files were counted using FIJI (version 1.49m, 
National Institutes of Health). Individual channels for green and magenta were opened and 
contrast was automatically enhanced. The channels were then merged and the z-stack 
compressed using the z-projection function to flatten all images in the stack to one image. 
The percentage of each type of Gal-3 labeling was determined by manual counting with 
the investigator blind to subject conditions. 
Statistics 
 All analyses were performed using the R-project (x64, version 3.10) and RStudio 
(version 0.98.1102) for statistical computing and an alpha significance level of 0.05. Three 
factor ANOVA with two between subject factors (age groups (3) X sex (2)) and one 
repeated measure (region (3)) was performed with subjects stratified by young, middle-age 
and old. When statistically significant differences were found by ANOVA, a Tukey A 
(HSD) post-hoc test was used to identify the critical factor while controlling for multiple 
comparisons. Linear regression analyses (alpha = 0.05) were conducted to assess the 
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relationship of LN3 cell density, Gal-3 cell density and Gal-3 morphological subtype 
density to age or cognitive function (in old animals only). A chi-squared test of 
independence was used to test differences in Gal-3 double labeling with LN3 between 
young and old animals. 
Results 
Galectin-3 phagocytic cell density increases with age 
 Examples of Gal-3 staining are shown in Figure 3.9A and 3.9B and the volume of each 
ROI and the estimated Gal-3 positive cell density is shown in Table 2 for each animal. To 
determine if the density Gal-3 positive staining (cells/mm3) differed by sex or ROI, animals 
were stratified into age groups (young, middle-aged, old) and ANOVA was used to assess 
the effects of age group, sex, and ROI. There were no significant differences in density of 
Gal-3 positive cells between regions (F(2,64) = 0.085, p = 0.919) or between sexes (F(1,64) 
= 0.026, p = 0.873), but Gal-3 cell density did approach significance by age (F(2,64) = 
2.763, p = 0.071, see Figure 3.10A) and there were no significant interaction effects 
between factors. A Tukey-A post-hoc analysis was performed comparing Gal-3 cell 
densities across sex, ROIs, and groups. This post-hoc analysis demonstrated that the 
density of Gal-3+ cells was significantly higher in old animals compared to both young (p 
< 0.00001) and middle-aged animals (p < 0.00001). Middle-aged animals did not 
significantly differ from young animals (p = 0.243). These differences were consistent for 
all ROIs.  
 To test the hypothesis that Gal-3 cell density increased with age, linear regression was 
used with age as a continuous variable. There was a significant age-related increase in the 
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density of Gal-3 positive cells in the CGB (Fig 5B, (F(1,26) = 29.9, p < 0.0001) with age 
accounting for approximately 51.7% of the variance in Gal-3 cell density (R2 = 0.517). 
Similarly in the FWM (Figure 3.10C), the density of Gal-3 positive cells significantly 
increased with age (F(1,27) = 31.6, p < 0.0005) which accounted for 52.2% of the variance 
in Gal-3 cell density (R2 = 0.522). Similarly, in the CC (Figure 3.10D), Gal-3 cell density 
significantly increased with age (F(1,26) = 17.3, p < 0.0005) where it accounted for 37.6% 
of the variance. 
LN3 activated microglial density increases regionally with age 
 LN3 positive staining can be seen in Figure 3.9C and 3.9D. To determine if there were 
statistical differences between LN3 cell density (cells/mm3) a 3-way ANOVA was run with 
subjects stratified by age, sex, and ROI. There was no significant effect of sex (F(1,35) = 
0.53, p = 0.473), but there were significant effects for region (F(2,35) = 7.72, p < 0.005) 
and age group (F(2,35) = 3.97, p < 0.05). There were no significant interaction effects. To 
further investigate the significant differences in age groups, one-way ANOVA analyses 
were performed between cell density and age group for each of the three regions. There 
were no significant differences in LN3 cell density between age groups in the CC (F(2,15) 
= 1.42, p = 0.272) or in the FWM (F(2,15) = 2.56, p = 0.111). However, LN3 cell density 
did differ significantly by group in the CGB (F(2,15) = 7.70, p < 0.005). Tukey post-hoc 
analysis revealed that old animals had significantly greater LN3 positive cell density 
compared to both middle-aged (p < 0.05) and young animals (p < 0.01, see Figure 3.11A).  
 Linear regression analysis was used to determine if density of LN3 positive cells in 
each region was associated with age. As shown in Figure 3.11B, the density of LN3 positive 
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cells in the CGB significantly increased with age (F(1,16) = 22.1, p < 0.0005), where age 
accounted for 54.0% of the variance in LN3 cell density (R2 = 0.540). In the FWM (Figure 
3.11C), the relationship between age and LN3 cell density approached significance 
(F(1,16) = 4.12, p = 0.059) and age explained 15.5% of the variance in LN3 positive cell 
density (R2 = 0.155). In the CC (Figure 3.11D), the relationship between LN3 cell density 
and age again approached significance (F(1,17) = 3.70, p = 0.072) but age accounted for 
only 13.0% of the variance in LN3 positive cell density (R2 = 0.13). 
Gal-3 cells are a subset of LN3 positive microglia 
 To determine if Gal-3 positive phagocytic cells also expressed the “activated” LN3 
phenotype, the percentage of Gal-3 cells double labeled with LN3 was determined in young 
and old animals using immunofluorescence and confocal microscopy. As shown in Figure 
3.12A-C, two different classes of cells were identified: 1) Single labeled: a cell that was 
Gal-3 positive and LN3 negative and 2) Double labeled: a cell that contained both Gal-3 
staining and LN3 staining. Additionally, as shown in Figure 3.12E, some of the double 
labeled cells had a distinct morphology with the Gal-3 signal contained within an LN3 
positive "balloon" within the LN3 positive cell, but without necessarily overlap of both 
labels. For all subjects, 91.3% of Gal-3 positive cells were double labeled with LN3 and 
only 8.7% were not. Additionally, of the Gal-3 positive cells 75.5% of Gal-3 staining 
showed almost complete overlap with LN3 whereas 15.8% of cells the Gal-3 positive 
signal was surrounded by an LN3 balloon (Figure 3.12D). To determine if the proportion 
of Gal-3 double labeled with LN3 differed between ages, a chi-square test was performed 
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and revealed no significant differences between young and old animals (χ2(1, N = 20) = 
0.767, p = 0.678). 
Density of hypertrophic and amoeboid Gal-3 cells predicts cognitive decline 
 To determine if microglial activation or phagocytic phenotype were associated with 
age-related cognitive impairment, linear regression was used to compare density to CII 
score of old animals (ages 20+ years) with each marker. CII was not associated with LN3 
cell density in the CGB (F(1,4) = 0.007, p = 0.937, R2 = 0.248) or the FWM (F(1,5) = 1.24, 
p = 0.317, R2 = 0.038), but was significantly predicted by LN3 cell density in the CC 
(F(1,4) = 8.37, p < 0.05, R2 = 0.551). However, this effect was largely driven by one animal 
(AM121). Using a multiple of 1.5 times the interquartile range, AM121 was identified as 
an outlier for CII score. When AM121 was removed, the CII score was no longer predicted 
by LN3 cell density in the CC (F(1,4) = 0.07, p = 0.799, R2 = 0.227).  
 For Gal-3, there was no relationship between cell density and CII in the CGB (F(1,11) 
= 0.27, p = 0.614, R2 = 0.065) or the CC (F(1,11) = 0.010, p = 0.923, R2 = 0.09). However, 
increased Gal-3 cell density in the FWM significantly predicted increased CII (F(1,12) = 
10.8, p < 0.01) accounting for 42.9% of the variance in CII score (R2 = 0.429, Figure 
3.13A). 
 To determine if the significant relationship of Gal-3 cell density in the FWM to CII 
score was due to phagocytic morphologies, linear regression was used to assess the 
relationship between the densities of ramified, hypertrophic, and amoeboid Gal-3 positive 
cells and CII of animals 20 years or older. While the density of ramified Gal-3 cells was 
not associated with CII (F(1,11) 0.98, p = 0.343, R2 = 0.002, Figure 3.13B), CII was 
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significantly predicted by the density of amoeboid Gal-3 cells (F(1,10) = 16.94, p < 0.005, 
R2 = 0.592, Figure 3.13C) and also by the density of hypertrophic Gal-3 cells (F(1,11) = 
0.05, p < 0.05, R2 = 0.357, Figure 3.13D).  
Discussion 
Summary 
 The current study utilized immunohistochemical labeling with Galectin-3 and LN3 
antibodies to identify phagocytic and activated microglial in the brains of cognitively 
assessed rhesus monkeys. In the cingulum bundle, corpus callosum and frontal white 
matter, Gal-3 and LN3 cell densities increased significantly with increasing age. Of the 
Gal-3+ phagocytic microglia, 90% co-localized with LN3 marker for activated microglia. 
In about 15% of the Gal-3 positive cells, the markers were not fully overlapped but, instead, 
showed a small Gal-3 positive outgrowth characterized as Gal-3+ phagocytic "balloons." 
While total numbers of double labeling and Gal-3 balloons increased with age, the 
percentage of double labeled Gal-3 and ballooned Gal-3 did not differ between age groups. 
To determine if either phagocytic activation or total microglial activation were related to 
the degree of age-related cognitive decline, the densities of Gal-3+ and LN3+ microglia 
were evaluated in behaviorally tested old monkeys (≥20 years of age). In these aged 
subjects, increased Gal-3+ cell density correlated with increased cognitive decline in the 
frontal white matter but not in the cingulum or the genu of the corpus callosum. In contrast, 
LN3+ cell density only correlated with cognitive performance in the corpus callosum 
although this was mainly driven by one animal that was very impaired. Since microglial 
morphology may be indicative of function (Karperien et al. 2013), we analyzed 
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morphological subtypes of Gal-3+ cells in the frontal white matter of the aged animals to 
determine if the previously identified correlation or Gal-3+ cell density and cognitive 
impairment was due to microglia with an activated morphology. While the density of Gal-
3+ cells with a ramified morphology was not related to cognitive impairment, the density 
of both hypertrophic and amoeboid subtypes was significantly associated with increased 
cognitive impairment.  
Functional Classification of Microglia by Immunohistochemistry and Morphology 
 Microglia have been dichotomized as M1/pro-inflammatory which corresponds with 
the classical notion of activation or as M2/anti-inflammatory which is an alternative 
activation state. In vitro, M1 activation is defined by responsivity to IFN-γ or LPS 
challenge causing release of pro-inflammatory cytokines such as TNF-α or IL-6, and 
production of reactive oxygen species. The alternative M2 activation is defined by 
responsivity to IL-4 leading to the release of anti-inflammatory cytokines such as TGF-β 
and IL-10 (for review on microglia activation, see Cherry et al., 2014). However, 
identifying, defining and interpreting activation states in vivo has been inconsistent 
(Gordon and Martinez, 2010; Prinz and Priller, 2014). For example, the current study 
utilizes LN3, an antibody to the HLA-DR MHC II surface receptor as a marker for 
microglial activation. Some report that MHC II expression increases with microglial 
“activation” following pathogen-associated molecular patterns (Town et al. 2005). 
However, MHC II expression is regulated by toll-like receptor stimulation and the M1 
activation pathway via IFN-γ (Ting and Trowsdale 2002) but nevertheless is associated 
with both pro- and anti-inflammatory phenotypes (Conde and Streit 2006). Hence, MHC 
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II expression can also be regarded as a marker for identifying the general population of 
microglia (Conde and Streit, 2006; Mittelbronn et al., 2001). While the Gal-3 literature is 
more consistent in that it is necessary for phagocytosis (Sano et al. 2003; Dumic et al. 
2006), Gal-3 has not been widely utilized in the brain and only recently recognized as a 
marker for phagocytic activation (Safaiyan et al. 2016). 
 Thus, immunohistochemical staining with LN3 or Gal-3 may not necessarily indicate 
the presence of one specific functional state (activation or phagocytosis). Rather Gal-3+ 
staining may simply indicate that the microglial cell is “primed” for phagocytic activation 
while the presence of LN3+ staining may indicate the cell is "primed" for inflammatory 
activation (Norden and Godbout 2013; Perry and Holmes 2014). Double labeling with LN3 
and Gal-3 would indicate that both processes are available when necessary. Consistent with 
this interpretation of microglia priming, Sierra et al. (2007) showed that while aged mice 
have higher baseline mRNA expression of both M1 cytokines (TNF-α, IL-6, IL-1β) and 
M2 cytokines (IL-10, TGF-β), when challenged with LPS, older mice have both more 
robust pro- and anti-inflammatory cytokine responses compared to young mice. This 
indicates that microglia that appear as “activated” by IHC, may be primed and ready to 
respond when challenged. Therefore, the current data demonstrate that both phagocytic 
priming (Gal-3+ cells) and general microglial activation increase with age in frontal white 
matter regions. Further, as over 90% of Gal-3 cells are co-labeled with LN3, it is clear that 
the majority of phagocytic primed cells are activated microglia.  
 Further insight into functional state may be gained by examining the morphological 
subtypes of labeled microglia. As reviewed by Karperien et al. (2013): ramified microglia 
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with small, round cell bodies and thin processes are thought to be non-inflammatory, 
surveilling the neuronal environment for damage (Nimmerjahn et al. 2005). In contrast, 
hypertrophic microglia are often polarized, with enlarged soma and denser processes 
representative of “activated” or inflammatory microglia (Lee et al. 2008). Amoeboid 
microglia with rounded somata and limited processes are indicative of phagocytic 
microglia (Bohatschek et al. 2001). Although these data suggest that morphology is 
indicative of function, no study to date has demonstrated exactly what cytokines are being 
released or what exact functions are occurring in each morphological state. Hence, the 
traditional M1/M2 dichotomy and division into "activated" and "resting" cells is being re-
examined (Ransohoff 2016). In the current study, phagocytic microglia stained for Gal-3 
are separated by these morphological subtypes. As expected, the Gal-3 positive cells were 
primarily hypertrophic (~60%) or amoeboid (~30%). Moreover, only the density of 
hypertrophic and amoeboid Gal-3+ cells correlated with cognitive impairment. The 
observation that ramified Gal-3+ cells do not change with age or predict cognitive decline 
suggests that there is a baseline number of Gal-3+ cells that are primed for phagocytosis 
but have not developed an inflammatory phenotype. The changes in total Gal-3+ staining 
likely indicates an increase in the number of cells taking on morphologies indicative of an 
inflammatory phenotype. This demonstrates that Gal-3 immunoreactivity is a useful 
marker for inflammation and phagocytosis in the brain. 
Microglial activation and phagocytosis throughout the lifespan 
 One hallmark of brain aging is chronic M1/pro-inflammatory activation of microglia 
(Cribbs et al., 2012; Holtman et al., 2015, see Norden and Godbout, 2013 for review). 
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Increased overall microglial activation with age has been reported using different IHC 
markers in rodents (Rozovsky et al. 1998; Sierra et al. 2007), monkeys (Sheffield and 
Berman 1998; Sloane et al. 1999), and humans (DiPatre and Gelman, 1997; Rogers et al., 
1988; Streit and Sparks, 1997). The current study confirms and expands upon this general 
finding by demonstrating that the density of LN3 (total activation) and Gal-3 (phagocytic 
activation) positive microglial increases with age in white matter pathways of the frontal 
lobe (the cingulum bundle, corpus callosum and frontal white matter). Bowley et al. (2010) 
and many others (Feldman and Peters, 1998; Peters and Sethares, 2002; Sandell and Peters, 
2003) have reported an age-related accumulation of myelin defects and axon loss in 
forebrain white matter pathways of the rhesus monkey (e.g. the corpus callosum and 
cingulum bundle, anterior commissure). Additionally, others have shown age-related loss 
of white matter volume in MRI (Guttmann et al. 1998; Wisco et al. 2008), increases in 
white matter hyperintensities in MRI (Tullberg et al. 2004; Wakefield et al. 2010) and 
increased myelin damage inferred by loss of fractional anisotropy from diffusion tensor 
imaging (DTI; Makris et al., 2007). As myelin defects accumulate with age, it is likely that 
microglia would be activated and participate in the clearance of damaged white matter and 
axons. Interestingly, neither LN3 nor Gal-3 antibodies show robust staining in the gray 
matter in young or old monkeys (data not shown). 
Phagocytosis and demyelination 
 Despite the large body of evidence that myelin is damaged and lost and microglia are 
activated with age, evidence of myelin removal has been limited. Peters & Sethares (2002), 
using electron microscopy, described small myelin fragments in astrocytes and less 
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frequently in microglia. This is in contrast to in vitro studies that report macrophages, such 
as microglia, phagocytose myelin at a greater rate than astrocytes (Williams et al., 1994). 
Other studies report that myelin phagocytosis is impaired with age (Ruckh et al. 2012; 
Natrajan et al. 2015) and can be inhibited by pro-inflammatory cytokines (Brück et al. 
1992; Liu et al. 2006). Thus, it is possible that the chronically pro-inflammatory microglia 
of the aging brain could slow the removal and phagocytosis of myelin debris (Rawji et al., 
2016).  
 In a demyelinating model of experimental autoimmune encephalomyelitis (EAE), Gal-
3 expression has been shown to increase (Reichert and Rotshenker 1999), but, despite this 
increase, myelin clearance in this model is insufficient to allow recovery of myelination to 
normal levels (Neumann et al. 2009). Similarly, studies have shown that if myelin debris 
is not removed, remyelination is impaired (Lampron et al. 2015). In this regard, it is also 
known that oligodendrocyte precursor cells are recruited to areas of demyelination, but 
differentiation into mature myelinating oligodendrocytes is impaired by myelin debris 
(Kotter et al., 2005; Kotter et al., 2006). These observations suggest that a limiting factor 
in repair and restoration of myelin may be the phagocytic capacity of the microglia to 
remove myelin debris.  
Phagocytic functionality 
 The data from the current study suggest that stimulation of phagocytosis increases with 
age in parallel with myelin damage. The correlation of increased phagocytic phenotype 
(amoeboid cells) with increased cognitive decline reported here and the age-related 
increase in myelin damage reported in this same model (see Peters and Kemper, 2012 for 
  
59 
review) likely means that phagocytosis is not sufficient to effectively remove damaged 
myelin (Ruckh et al. 2012; Natrajan et al. 2015). Hence, the observed increase in Gal-3 
positive microglia with age could indicate that microglia have been “primed” for 
phagocytosis by detection of deteriorating myelin, but are either dysfunctional or the 
amount/rate of myelin damage is too much for microglia to efficiently phagocytose the 
debris. As more myelin debris accumulates and is not repaired, a vicious cycle could result 
in which more microglia are recruited and release pro-inflammatory cytokines, but fail to 
remove sufficient myelin debris to allow for remyelination and resolution of inflammation 
(Ruckh et al. 2012; Natrajan et al. 2015). 
 In our immunofluorescence study of Gal-3 co-localization with LN3, approximately 15% 
of the cells had a distinct balloon-like formation extending from an otherwise normal looking 
LN3+ microglial soma. This feature resembles the phagocytic cups previously described in 
vitro (Kay et al., 2006; Leverrier & Ridley, 2001; Murray et al., 2005). These actin-dependent 
cups form during the initial stages of phagocytosis as a macrophage begins to engulf debris. It 
would be expected that the percentage of microglia displaying these phagocytic cups would 
increase with accumulating damage. To the extent that presence of Gal-3+ phagocytic balloons 
are markers of phagocytic function, the present data showed no difference in the percentage of 
cells double-labeled cells with phagocytic cups between young and old animals. Since all 
evidence suggests that white matter in the aged brain likely contains significant myelin 
damage, the lack of an increase in the percentage of microglia with phagocytic cup suggests 
an impairment in phagocytic responsivity. 
Phagocytic capacity and age-related neurodegenerative diseases 
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 With age, microglia have been described as dystrophic and senescent (Streit et al. 2004), 
but the functionality and phagocytic capacity of these senescent microglia is unknown. In a 
recent study in mice, Safaiyan et al. (2016) identified an age-related increase in Gal-3 
microglia and an increase in microglia contacting myelin visualized by double label IHC, 
suggesting that microglia not only have increased phagocytic activation, but also that this 
increased activation may be related to myelin. Similar inefficient debris clearance has been 
seen in age-related neurodegenerative diseases such as Alzheimer's, where β-amyloid 
aggregation is also thought to be related to an impaired phagocytic capacity of microglia 
(Chung et al. 1999; Lucin et al. 2013; Hickman and El Khoury 2014). These data suggest 
that age-related impairment of microglial phagocytosis is not limited to myelin. However, 
the question still remains as to the cause of the impaired microglial function. For example, 
perhaps age-related accumulations of a variety of protein aggregates like amyloid as well 
as myelin debris overburden microglia. Alternatively, perhaps microglia functionality 
simply declines with age, allowing damage to go unresolved? These questions must be 
considered not only in aging, but also in neurodegenerative diseases where debris clearance 
could play a key role in disease progression. Further, as the leading risk factor for 
neurodegenerative diseases is age (Mayeux and Stern 2012), it is possible that the burden 
of myelin debris may play a role in the ability of microglia to deal with other damage in 
the brain, such as amyloid plaques, phosphorylated tau oligomers, or α-synuclein 
aggregates. 
Autophagy and aging 
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      While phagocytosis is important for the clearance of cellular debris, autophagy is the 
process required for normal maintenance of cellular function through breakdown of 
intracellular debris (Glick et al. 2010). Data indicate that inhibiting autophagy in mice 
decreases lifespan and increases protein aggregation (Hara et al. 2006; Komatsu et al. 
2006). In contrast, increasing autophagy in worms (Hansen et al. 2008) and flies (Simonsen 
et al. 2008) extends lifespan. Interestingly, calorie restriction without malnutrition 
increases autophagy in rats (Kume et al. 2010) and extends life span (Weindruch and 
Walford 1982) and monkeys (Mattison et al. 2017). While the exact mechanism by which 
calorie restriction enhances autophagy is unclear, it is thought to involve AMPK or Sirtuin 
1 stimulation or insulin-like growth factor inhibition (Johnson et al. 2013). Although both 
autophagy and phagocytosis show age-related functional changes, little is known about 
possible linkage between these clearance mechanisms. Additionally, it is unknown why 
these mechanisms for degradation become faulty with age and whether these changes occur 
in monkeys. 
Cognitive decline and phagocytosis 
 While the density of LN3+ and Gal-3+ microglia increase significantly with age, it is 
curious that Gal-3+ cell density in the FWM was the only strong correlate with cognitive 
impairment. While some have reported that cognitive impairment is predicted best by total 
frontal white matter (Tullberg et al., 2004, Wakefield et al., 2010), others have claimed that 
regional specificity is important (Bowley et al., 2010, Head, 2004, Mielke et al., 2009). 
Bowley et al. (2010) showed myelin defects are specifically correlated with cognitive 
decline in the cingulum, but not the corpus callosum. However, DTI data from Mielke et 
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al. (2009) and Head (2004) suggest that frontal white matter damage, but not temporal or 
occipital, correlate with cognitive performance. The specificity of the current finding of a 
relationship of Gal-3 with cognitive impairment only in FWM could suggest that myelin 
damage was more severe in this area, leading to more microglia being primed for 
phagocytosis but ultimately ineffective in allowing remyelination. This is consistent with 
our additional observation that within the FWM, the density of both hypertrophic 
(activated) and amoeboid (phagocytic) Gal-3+ cells correlated with cognitive decline while 
the density of ramified (resting) microglia did not. It further suggests that these microglia 
are not functioning properly and allow myelin damage to accumulate, leading to an 
increase in the number of microglia recruited and activated and a continuation of the 
inflammatory response. The specificity of this finding to the FWM might indicate 
especially faulty clearance mechanisms in this region, i.e. a particular vulnerability. 
However, it is possible that Gal-3+ microglia are simply acting as a surrogate marker for 
the overall white matter damage and general aging dysfunction. Understanding the regional 
differences in myelin damage and age-related pathologies is essential to determining the 
relation of inflammation to and the causes of age-related cognitive decline. 
Conclusions 
 During aging, myelin deteriorates and appears to be a strong predictor of the age-related 
cognitive decline seen in normal aging (Bartzokis 2004; Peters 2009). As the myelin debris 
accumulates, it likely leads to the increased recruitment of the activated and phagocytic 
microglia observed in the present study. In a healthy adult, this would trigger an acute 
inflammatory response supporting microglial phagocytosis and clearance of the debris, 
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resolving with oligodendrocyte precursor cell differentiation and remyelination. However, 
with aging, the capacity of microglia to clear the myelin debris likely declines as shown by 
Plowden et al. 2004 and Safaiyan et al. 2016, leaving microglia unable to effectively respond 
to the damage and remyelination impeded by inhibition of oligodendrocyte differentiation. 
Similar phagocytic inefficiencies may also contribute to the vulnerability of the brain to age-
related neurodegenerative diseases. Thus therapeutics targeting the phagocytic functionality of 
aging microglia could prove useful not only in facilitating remyelination, and slowing or even 
reversing age-related cognitive decline, but might also be valuable in treating age-related 
neurodegenerative diseases. 
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Figure 3.6. Subject comparison between studies. For both the cohort of subjects in the A) 
Gal-3 analysis and those in B) the LN3 analysis, linear regression analyses show that cognitive 
impairment index (CII) scores increase significantly with age. There is a statistical outlier with 
severe impairment that drives the LN3 effect, but, even with this subject removed the increase 
in CII with age is still significant (R2 = 0.253, p < 0.05). 
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Figure 3.7. Regions of interest. Nissl stained sections from the NIH Blueprint NHP Atlas, 
(http://www.blueprintnhpatlas.org/static/home) show the approximate rostral and caudal 
boundaries for each region of interest analyzed: the cingulum bundle (CGB, red), frontal white 
matter (FWM, yellow) and anterior part of the body of the corpus callosum (CC, black). For 
the Gal-3 experiment, the CGB was sampled between AP +30.00 (A) and AP +25.50 (B), 
whereas, for the LN3 experiment, the CGB was sampled between AP +17.45 (C) and AP +0.30 
(D). For both Gal-3 and LN3 experiments the FWM was analyzed from AP +30.00 (A) to AP 
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+25.50 (B). For the LN3 analysis, cells in the CC were counted within the black solid boundary. 
For the Gal-3 experiment the CC region of interest included the solid black line plus the region 
within the black dotted line. Interaural measurements estimated from Paxinos, Huang, & Toga 
(2000). 
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Figure 3.8. Morphological characterization of Gal-3 positive cells. Bright field 
photomicrograph of Gal-3 immunolabeling (brown) with thionin counterstain (blue) in FWM 
showing microglial morphology as follows: A) Ramified microglia contain dense cell bodies 
and thin processes distributed around the cell. B) Amoeboid microglia are characterized by 
large, round stained cells with only a few, short processes or no processes. C-D) Hypertrophic 
Gal-3 positive cells are found in a variety of shapes and sizes but range from cells with C) an 
elongated cell body and short, dense processes to D) cells with a densely stained and curved 
cell body with short, dense processes or intense cell body staining with thin processes 
extending outwards. Scale bar = 20µm.  
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Figure 3.9. Typical staining in the Frontal White Matter for Gal-3 and LN3 positive cells. 
A) The scarcity of Gal-3 staining in a young subject compared to B) the robust staining for an 
aged subject. C) Similarly, we see sparse LN3 positive staining in a young subject compared 
to D) dense staining in an aged subject. A thionin counterstain was used for Gal-3 stained 
sections, as indicated by blue staining seen in A and B. Scale bar = 0.1mm 
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Figure 3.10. Galectin-3 stereological quantification. A) Bar graphs comparing mean Gal-3 
cell density for each region stratified by age groups. A 3-way ANOVA demonstrated that while 
there were no significant effects of sex or regions, there was a significant effect of age groups. 
Tukey-A post-hoc analysis demonstrated that within each region of interest, Gal-3 cell density 
was significantly greater in old animals compared to young and middle-aged animals. B-D) 
Scatterplots of Gal-3 cell density in each region of interest. Linear regression analysis showed 
that Gal-3 cell density was positively associated with age in all three regions. *p < 0.05, ***p 
< 0.0005 
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Figure 3.11. Stereological quantification of LN3. A) Bar graphs displaying mean LN3 cell 
density for each region stratified by age group within each region of interest. A 3-way ANOVA 
demonstrated that there was no significant effect of sex, but there were significant effects of 
age groups (P < 0.05) and within regions (P < 0.005) with no significant interactions. Tukey-
A post-hoc analysis demonstrated that within the CGB, LN3 cell density was significantly 
greater in aged subjects compared to middle-aged (P < 0.05) and young (P < 0.01). B-D) 
Scatterplots of LN3 cell density in each region of interest. B) Linear regression analysis 
demonstrated that LN3 cell density was positively associated with age in the CGB and C, D) 
approached a statistical association in the FWM and the CC. *P < 0.05 
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Figure 3.12. Analysis of LN3 and Gal-3 double labeling. Confocal images were taken in a 
z-stack and z-projected image of standard deviation of mean intensity using FIJI software. 
Examples for A) LN3 only (green) and B) for Gal-3 only (magenta). C) The merged image 
and shows one cell with co-localization in white (white arrow) while the other three cells 
indicated by yellow arrows remain single labeled for LN3. D) Gal-3 is found in 91.3% of LN3 
positive cells while 8.7% of Gal-3 cells do not colabel with LN3 positive cells. E) A subset of 
the Gal-3 and LN3+ double labeled cells contained small, round, offshoots of LN3 that 
surrounded, but did not always colocalize with Gal-3 staining. These offshoots are referred to 
as “balloons” and one is indicated by the red arrow. Scale bars = 50µm. 
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Figure 3.13. Galectin-3 cell quantification in age-related cognitive decline. Scatterplots 
showing the linear relationship of cognitive impairment (CII) to Gal-3 positive cell density in 
total and by morphological subtypes in the FWM of old animals (ages 20+). Regression 
analysis showed that CII is significantly related to A) total Gal-3 cell density, but not B) to the 
density of ramified Gal-3 cells. However, the density of C) amoeboid Gal-3 cells and D) 
hypertrophic Gal-3 cells both significantly predicted by CII score. This suggests that only the 
inflammatory-associated amoeboid and hypertrophic morphologies of Gal-3 cells are 
associated with increased cognitive impairment.  
  
  
73 
CHAPTER 4: LIPOFUSIN LOCALIZATION IN WHITE MATTER GLIAL 
CELLS 
Introduction 
 One of the most long-standing theories of cellular aging and senescence is the “free 
radical theory of aging” first proposed by Harman in 1956. This continues to be a major 
hypothesis despite decades of data and debate (see Liochev 2013; Viña et al. 2013; 
Gladyshev 2014; Reeg and Grune 2015). The theory posits that reactive oxygen species 
(ROS) increase with age and cause excessive oxidative stress that leads to cellular damage. 
ROS are primarily produced by mitochondria as a function of metabolism and electron 
transport (Turrens 2003; Kregel and Zhang 2007). However, ROS can also be induced by 
intrinsic factors such as cytokines (Yang et al, 2007) and growth factors (Bae et al. 1997). 
Excess ROS and resulting oxidation can cause severe cellular damage including protein 
modifications and misfolding as well as damage to lipids and to DNA (Kregel and Zhang 
2007). The mitochondrial-lysosomal axis theory of aging stems from the oxidation 
hypothesis by proposing that ROS-induced dysfunctions to mitochondria create a feed 
forward loop with increased ROS production and generation of more cellular debris that 
needs to be degraded by the lysosome (Brunk and Terman 2002a). Lysosomes, either 
overburdened or dysfunctional themselves, are unable to keep up with the amount of 
material needing to be degraded leading to accumulation of intracellular debris aggregates 
and impaired autophagy (Terman 2001).  
 Proteins are more likely to become oxidized with increased ROS generation, a process 
that can lead to protein cross-linking (Stadtman and Berlett 1997). Oxidized proteins are 
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targeted for degradation through the ubiquitin-20S proteosome pathway (Davies 2001; 
Jung et al. 2014). During degradation, cross-linked proteins can interact with other cellular 
debris such as lipids, sugars, and metals to undergo a Fenton reaction, creating a non-
degradable aggregate called lipofuscin (Terman and Brunk 1998; Höhn et al. 2013). 
Lipofuscin is formed primarily by proteins (approximately 30-70%) and lipids (20-50%), 
but also contains trace amount of metals (primarily iron) and carbohydrates (Brunk and 
Terman 2002a). Due to the heterogeneity of lipofuscin accumulations, there is no standard 
antigenic target to use for detection. However, the oxidized protein carbonyls and amino 
groups of lipofuscin undergo reactions that create Schiff bases that autofluoresce (Yin 
1996).  
 It is well documented that lipofuscin increases linearly with age, especially in cells that 
are long lived or don’t turn over (see Brunk and Terman 2002; Höhn et al. 2013; Reeg and 
Grune 2015). In the brain, some neurons, most notably Betz cells, evidence large amounts 
of lipofuscin accumulation (Peters and Sethares 1993). while others in the same region do 
not (Tigges et al. 1990). However, cellular function of neurons does not seem affected by 
lipofuscin accumulation (Tigges et al. 1990) and neuronal loss does not occur with age 
(Peters et al. 1998; Merrill et al. 2000). Additionally, many, but not all glial cells in the 
gray matter also show age-related increases in lipofuscin (Peters et al. 1991).  
 MRI studies on the aging brain in humans and monkeys show little change in total gray 
matter volume with age but instead show a loss of white matter volume (Wisco et al. 2008, 
Guttmann et al. 1998). Light microscopy also supports age-related white matter pathology 
showing a decrease in the total length of myelinated fibers in the human brain (Tang et al. 
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1997; Marner et al. 2003) even as neuron numbers are preserved (Terry et al. 1987; 
Freeman et al. 2008). At the ultrastructural level, there is an age-related increase in myelin 
pathology along with a loss of myelinated fibers particularly in frontal white matter regions 
(Bowley et al., 2010, Li et al., 2017). These myelin defects have been observed in the visual 
cortex (Peters, Moss, & Sethares, 2000), the optic nerve (Sandell and Peters, 2002), fornix 
(Peters et al., 2010) and the anterior commissure (Sandell & Peters, 2003). In addition, both 
white matter volume and myelin damage correlate with age-related cognitive decline 
(Albert 1993; Bowley et al., 2010). 
 Although there is strong evidence for age-related white matter dysfunction, few studies 
have investigated lipofuscin accumulation in the white matter. Safaiyan et al (2016) found 
that the number and volume of lipofuscin clusters increases in white matter microglia with 
age. Additionally, the size of lipofuscin clusters in microglia was found to be larger than 
that of those in the gray matter. Finally, myelin debris removal by microglia increased the 
amount of lipofuscin within the cells.  
 In this study, we quantified lipofuscin accumulation within the frontal white matter and 
cingulum bundle of behaviorally tested aging rhesus monkeys to determine if there was an 
age-related increase in lipofuscin density and size that are also associated with cognitive 
impairment. Additionally, we investigated the localization of lipofuscin in white matter 
microglia, astrocytes and oligodendrocytes. Our results demonstrate a relationship between 
white matter lipofuscin size and cognitive impairment. Through our analysis of glial cells 
and lipofuscin, we present the framework for understanding how lipofuscin accumulation 
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in the white matter could be disrupting glial processes of autophagy and myelination, 
leading to myelin damage and impaired cognition. 
Methods 
Subjects 
 Brain tissue from 30 rhesus monkeys was used in this study. This tissue had been 
collected and stored as part of an NIA funded Program Project ("Neural Substrates of 
Cognitive Decline in Aging Monkeys", P01-AG000001) and a Research Project 
("Histopathology, Neuroimaging and Mechanisms of Myelin Damage in Aging Monkey 
Brain", R01-AG043640). Of the monkeys used in this study, 28 were obtained from the 
Yerkes National Primate Research Center at Emory University in Atlanta and 2 animals 
came from other research centers. Prior to selection, health records were screened with 
strict health criteria to exclude any possible confounding clinical diseases or experimental 
manipulations that could impact normal aging by affecting the brain or behavior.  
 Previous studies of rhesus monkey survival and of cognitive decline suggest that the 
rhesus monkey ages at an approximate ratio of 1 year for every 3 human years (Tigges et 
al., 1988). Using this, animals were subdivided into age groups of young adult (ages 8.1 - 
13.7), middle-aged (ages 16.0 -19.9) and old (ages 20+). Although stratifying animals by 
age range allows for easy classification of each animal, in statistical analyses, age was also 
used as a continuous variable in linear regression to identify changes that occur across the 
lifespan.  
Behavioral testing 
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 All monkeys received a series of behavioral tests that assess cognitive functions. The 
major tasks used in this study were a test of rule learning using acquisition of the Delayed 
Non-Match to Sample (DNMS) task, extended delays on DNMS (120 sec and 600 sec) to 
test recognition memory, the Delayed Recognition Span Test in both spatial and object 
modes to assess working memory capacity, and the Category Set Shifting Task (CSST) to 
test executive function (Herndon et al. 1997; Moore et al. 2005). Based on a principal 
components analysis (Herndon et al., 1997), a subset of the DNMS and DRST scores were 
identified as the best predictors of cognitive aging and were compiled into a z-score 
designated the cognitive impairment index (CII). This has proven useful in comparing 
cognitive status with neurobiological endpoints (e.g. Peters, Sethares, & Moss, 1998). 
Middle-aged and old animals (ages 16+) were divided into groups of cognitively spared 
(CII < 2) and cognitively impaired (CII > 2) to investigate factors that exacerbate age-
related cognitive decline. 
Brain perfusion and tissue section preparation and storage 
 After behavioral testing was completed, monkeys were deeply anesthetized with 
sodium pentobarbital and transcardially perfused through the aorta with ice cold Krebs 
Henseleit buffer (pH 7.4, 4°C) for five minutes during which fresh biopsy samples for in 
vitro neurophysiology or biochemical analyses were harvested. Subsequently the perfusate 
was switched to 4 liters of 4% buffered paraformaldehyde (pH 7.4, 37°C) which was 
perfused over 10 minutes. Immediately after perfusion, the brain was blocked in the coronal 
stereotactic plane, removed from the skull and placed in the 4% paraformaldehyde fixative 
overnight at 4°C. The brain was then transferred through successive incubations in 0.1M 
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phosphate buffer containing first 10% glycerol with 2% DMSO and then buffer with 20% 
glycerol and 2% DMSO until the brain equilibrated for cryoprotection (Rosene et al. 1986). 
Finally, the brain was flash frozen in -75°C isopentane after which it was stored at -80°C 
until it was cut on a freezing microtome into 10 interrupted series of 30 µm thick sections. 
Brain tissue sections were collected in buffer with 15% glycerol as a cryoprotectant, 
equilibrated overnight at 4°C and then frozen and stored at -80°C until removed and thawed 
for immunohistochemistry.  
Immunohistochemistry 
 Six experiments using single immuno-fluorescence labeling methods were employed 
to label microglia (Iba1), astrocytes (glial fibrillary acidic protein (GFAP), 
oligodendrocytes (Olig-2), oligodendrocyte precursor cells (platelet derived growth factor 
α (PDGFRΑ), mature oligodendrocytes (CC1 clone of the APC protein) and lysosomes 
(LAMP-1). For each animal, one tissue section containing frontal white matter and 
cingulum bundle was used for each label and processed individually. Immunofluorescence 
was performed as described previously (Shobin et al, 2017), with slight changes necessary 
for optimal staining of each label. Briefly, tissue sections were washed in 0.05M tris 
buffered saline (TBS). For PDGFRΑ staining, sections underwent heated antigen retrieval 
in Citrate Buffer (pH 6.0) using a PELCO Biowave Pro microwave (Ted Pella, Inc., 
Redding, CA) for 5 minutes at 550W with a maximum temperature of 40°C followed by a 
one hour incubation at room temperature. All sections were then washed in buffer and 
blocked with SuperBlock (ThermoFisher Scientific, Waltham, MA) for one hour before 
overnight incubation in primary antibody at room temperature in carrier solution of 0.5% 
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SuperBlock and 0.5% Triton X in 0.05M TBS (goat anti-Iba1, 1:1000, Abcam, Cambridge, 
MA; mouse anti-GFAP, 1:500, Dakocytomation, Glostrup, Denmark; rabbit anti-Olig2, 
1:750, Abcam, Cambridge, MA; mouse anti-CC1 (APC), 1:500, Millipore-Sigma, 
Burlington, MA; rabbit anti-PDGFRα 1:500, Cell Signaling Technologies, Danvers, MA; 
rabbit anti-LAMP-1, 1:1000, Abcam, Cambridge, MA). For PDGFRΑ staining, sections 
were incubated in a 0.05M TBS solution with a pH of 9.0 and left incubating in primary 
antibody for an additional night at 4°C. Next, tissue sections were washed in buffer and 
incubated for two hours in secondary antibody solution containing 0.5% SuperBlock, 0.5% 
Triton X, and an AlexaFluor 488 (or AlexaFluor 647 for LAMP-1) tagged for the 
appropriate animal at 1:1000 dilution (donkey anti-goat, donkey anti-rabbit, or donkey anti-
mouse, Invitrogen, Carlsbad, CA). Sections were then washed in buffer, slide-mounted and 
coverslipped using anti-fade polyvinyl mounting media containing DABCO (Millipore-
Sigma, Burlington, MA). Slides were stored in 4°C before confocal analysis.  
Autofluorescence quantification 
 A Leica TCS SPE laser scanning confocal microscope (Buffalo Grove, IL) was used to 
visualize fluorescence and acquire images for analysis. Four sections from each animal 
were used for autofluorescence quantification. Tissue was either immunostained with Iba1, 
Olig2, or GFAP or the tissue was slide mounted and coverslipped without any processing. 
Confocal z-stacks of 10 optical slices were taken using a 20X/0.75 objective lens of each 
animal in the frontal white matter. Unprocessed tissue was excited using the 488nm laser 
and emission was collected with a 500-700nm bandpass filter. Autofluorescence from 
sections labeled with Iba1, Olig2, and GFAP was excited with the 561nm laser and 
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emission was collected with a 570-620nm bandpass filter. To determine the number of 
optical slices, the z for each image was set by the points where no fluorescence could be 
seen on either side of the section. Image pixel size was set at 1.76 pixels/ μm and the z step 
size (and number of z-slices) were determined using the automated system optimized 
settings based on the diffraction limit of the objective. FIJI software (version 1.51i, 
National Institutes of Health) was used to open Z-stack images contained in .LIF files and 
conduct analyses of each stack. Images were split into individual channels and thresholded 
using the triangle method in the Threshold tool. The percent area of white matter occupied 
by thresholded fluorescent label was assessed on standard deviation intensity z-projection 
images of each confocal z-stack using the Analyze Particle tool in FIJI. The size of 
fluorescent objects was quantified by the Analyze Particle tool (on the z-projection image) 
and the 3-D Object Counter tool (on the confocal z-stack) in FIJI.  
Co-localization of lipofuscin and glial markers. 
 Sections stained with Iba1, GFAP, Olig2, CC1, and PDGFRΑ were visualized using a 
Leica TCS SPE laser scanning confocal microscope (Buffalo Grove, IL). Dual channel 
confocal imaging was achieved using a multitrack set-up, with sequential excitation, 
followed by sequential emission of two channels. First, immunofluorescence was excited 
using the 488nm laser and emission was collected between 500-555nm. Subsequently, 
lipofuscin autofluorescence was detected using excitation from a 561nm laser and emission 
collected between 570- 625nm. Confocal z-stack tiff images of 10 optical slices were each 
taken in the frontal white matter of each tissue section. Channels were separated into two 
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separate images for co-localization analysis using Coloc2. Correlation between glial 
immunolabeling and lipofuscin was assessed for degree of overlap using Pearson’s R.  
Co-localization of lipofuscin and lysosomes 
 To measure co-localization of lysosomes with lipofuscin, nine animals (3 young, 3 old 
spared, and 3 old impaired) were stained with LAMP-1 antibody and imaged using a 
confocal microscope at an optical slice of 0.68μm as described above. FIJI software was 
used to separate z-stack images into individual slices and then separated by channel into 
an image containing lipofuscin and an image containing LAMP-1. The lipofuscin image 
was then thresholded into a binary image used to generate regions of interest (ROIs). These 
ROIs were then overlaid onto the corresponding LAMP-1 image and the percent area 
occupied by LAMP-1 was measured. 
Microglial morphology 
 Microglia morphology was adapted from the cluster analysis of Karperien et al (2013) 
and updated from Shobin et al (2017). Z-stack images of microglia labeled with Iba1 were 
used from the previous co-localization analysis. Briefly, microglia were identified as either 
ramified or hypertrophic. Ramified microglia had small, semi-rounded soma with many 
thin processes extended. Hypertrophic microglia were all other microglia that came in 
many distinct shapes and sizes including enlarged or elongated cell bodies, dense or 
thickened processes, or few processes to no processes with an amoeboid shape. Cells were 
characterized by morphological subtype and whether they contained a lipofuscin cluster. 
The percentage of ramified cells containing lipofuscin and the percentage of hypertrophic 
cells containing lipofuscin were quantified and compared across age. 
  
82 
Microglia soma volume quantification 
 Using the same microglia images, soma volumes were quantified using Neurolucida 
360 software (MBF Biosciences). Soma were reconstructed and characterized as single 
labeled or colocalized with lipofuscin. Cluster analysis was used to determine bins of 
"small" and "large" microglia based on soma size. Interactions were determined using 
ANOVA and Chi-square tests for independence. 
Autofluorescence spectra analysis 
 To assess autofluorescence, one section per animal was mounted onto gelatin coated 
slides, air dried for one hour, and coverslipped using polyvinyl alcohol mounting media 
containing DABCO (Millipore-Sigma, Burlington, MA). A Carl Zeiss LSM 710 NLO 
microscope with spectral image lambda stack functionality was used to determine the 
emission spectral profile of autofluorescence. Tissue was excited with three lasers and 
emission detected at distinct intervals as follows: an argon laser that excites at 488nm with 
emissions collected between 490 - 720nm, a 561nm laser with emissions detection between 
570 TO 720nm, and a 633nm laser with emission detection between 640 TO 720nm. For 
each animal, a spectral lambda stack was created at a randomly chosen point in the frontal 
white matter. Ten autofluorescent objects (presumably lipofuscin) were selected and 
emission profiles of those ten objects were collected with each laser. After background 
subtraction, the emission profiles of the ten objects were averaged together to get the 
average emission profile for each animal at each of the three excitations used. 
Statistics 
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 Linear regression was used to compare variables to age whereas one way ANOVA 
and t-tests were used to determine differences in variables between age and cognitive 
groups, respectively. For all analyses, alpha was set to 0.05.  
Results 
Autofluorescence in the white matter increases with age 
 Images of lipofuscin associated autofluorescence can be seen in Figure 4.14A and 
B. To evaluate autofluorescence throughout age, particle analysis on standard deviation 
intensity z-projection images of confocal z-stacks was used to determine the changes in the 
percent area of autofluorescence. For size analysis of autofluorescent puncta, we used both 
particle analysis on 2D z-projection images and 3-D object analysis on confocal z-stacks. 
As expected, there was an age-related increase in the percent area of autofluorescence in 
the FWM (F(1,29) = 22.62, P = 0.000054, R2 = 0.427, Figure 4.14C), but not in the CGB 
(F(1,28) = 2.58, P = 0.119, R2 = 0.051, Figure 4.14D). We then used 3-D object analysis 
to determine volume and surface area for autofluorescent objects. There was a significant 
positive correlation between the average object volume and age in both the FWM (F(1,29) 
= 19.74, P = 0.00012, R2 = 0.385, Figure 4.14E) and the CGB (F(1,28) = 21.7, P = 0.00007, 
R2 = 0.417, Figure 4.14F).  
 We next groups animals by age into groups of young (6.2 - 13.7), middle-aged (16-
19.8), and old (20.7 - 30.2) to determine differences in object volume distribution by age. 
For each animal, autofluorescent puncta were separated into three bins based on object 
volume: objects of under 10 voxels3, 10 to 49 voxels3, and over 50 voxels3 for both the 
FWM and the CGB ROIs. Performing a MANOVA to assess overall differences in object 
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size per size bin across age groups and ROI, we found a significant effect of age groups 
(F(12,42) = 2.025, P = 0.046), but not statistically significant effects between ROIs with 
no interactions. To examine this further, we analyzed each bin separately using ANOVA 
to find differences between age-groups in only the CGB for mean volume of objects under 
10 voxels3 (F(2,27) = 5.285, P = 0.0116) and objects over 50 voxels3 (F(2,27) = 6.684, P = 
0.004). In both cases, Tukey post-hoc testing revealed that, compared to old animals, young 
animals had a greater percentage of objects under 10 voxels3 (P = 0.01). However, old 
animals had a significantly greater proportion of objects over 50 voxels3 compared to both 
young (P = 0.006) and middle-aged animals (P = 0.035).   
The size of autofluorescent objects is increased with greater cognitive impairment 
 Middle-aged and old animals (ages 16+) were separated into groups of cognitively 
spared (CII < 2) and cognitively impaired (CII > 2) to compare density and sizes of 
autofluorescent objects using the same methods as described previously (see Figure 4.15A-
B for example images). Interestingly, there was no significant difference based on 
cognitive impairment in percent area of autofluorescence in either the FWM (T(21) = 1.43, 
P = 0.084, Figure 4.15C) or the CGB (T(20) = 0.43, P = 0.366, Figure 4.15D). The average 
object volume, however, was significantly greater with cognitive impairment in both the 
FWM (t(21) = 2.23, P = 0.0184, Figure 4.15E), and the CGB (t(20) = 1.72, P = 0.05, Figure 
4.15F).  
Autofluorescence in the white matter primarily colocalizes with microglia and 
oligodendrocytes 
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 To determine which glial cells colocalized with lipofuscin associated 
autofluorescence, we used the Coloc2 plug-in for FIJI to calculate a Co-localization 
Coefficient (CLC) based on a pixel-by-pixel Pearson’s correlation of signal intensity 
between the two channels for each image stack. The greater the CLC, the higher the degree 
of signal co-localization between the two channels. For this analysis, one animal was 
excluded for all stains due to tissue quality after processing. A second animal was excluded 
from Iba1 analyses due to lack of noticeable staining. Example co-localizations for each 
marker can be seen in Figure 4.16A-C. We compared the average CLC for each glial 
marker using a within-subjects ANOVA. Significant differences between lipofuscin co-
localization with glial cell types were detected (F(2,83) = 3.879, P = 0.0245). To further 
determine differences in co-localization of lipofuscin with distinct glial types, we used 
paired t-tests to compare CLC (see Figure 4.16D). Lipofuscin co-localization with Iba1 
was significantly greater, with a greater average CC, than co-localization with GFAP (t(28) 
= 14.79, P < 0.0001) and Olig2 (t(28) = 3.20, P = 0.0034). Additionally, lipofuscin co-
localization with Olig2 was significantly greater than co-localization with GFAP (t(28) = 
8.55, P < 0.0001).  
 Next, we looked for age-related changes to lipofuscin co-localization with each 
glial stain. We found a significant age-related increase in lipofuscin co-localization with 
Iba1 (F(1,28) = 8.089, P = 0.00839, R2 = 0.202, Figure 4.17A) and with Olig2 (F(1,29) = 
23.25, P = 0.00004, R2 = 0.434, Figure 4.17C).  There was a statistical trend for an age-
related increase in lipofuscin co-localization with GFAP (F(1,29) = 4.11, P = 0.052, R2 = 
0.100, Figure 4.17B). 
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 Finally, we separated middle-aged and old animals (ages 16+) into groups of 
cognitively spared (CII < 2) and cognitively impaired (CII > 2) to determine differences in 
lipofuscin colabeling with each glial marker. We found no significant difference in 
colabeling between cognitive groups for any marker.  
Hypertrophic microglia containing lipofuscin increase with cognitive impairment 
 To assess if microglia morphology was related to lipofuscin co-localization, we 
analyzed an average of 140 iba1 labeled microglia from 29 animals. Cells were classified 
as either ramified (Figure 4.18A) or hypertrophic (Figure 4.18B-C) based on 
morphological appearance. To aid in morphological quantification, images were digitally 
magnified 4X using FIJI with a pixel size of 1.76 pixels/μm (Figure 4.18D-E). Each cell 
was further identified as either containing no lipofuscin or containing lipofuscin. Previous 
work has established that microglia inflammation and hypertrophic phenotypes are 
associated with age (Shobin et al. 2017). We verified this finding by establishing an age-
related increase in the percentage of microglia with a hypertrophic morphology (F(1,27) = 
11.46, P = 0.000547, R2 = 0.339, Figure 4.19A). We next hypothesized that a greater 
percentage of hypertrophic microglia would contain lipofuscin compared to ramified 
microglia. However, we found that there was no difference in the percentage of ramified 
cells that contained lipofuscin and the percentage of hypertrophic cells that contained 
lipofuscin (t(28) = 0.5466, P = 0.589).  
 Next, we hypothesized that the percentage of microglia containing lipofuscin would 
be greater in cognitively impaired animals. Old animals (ages 20+) were stratified into 
groups of cognitively spared (CII < 2) and cognitively impaired (CII > 2). The percentage 
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of total microglia that contained lipofuscin was increased in cognitively impaired animals 
(t(20) = 2.20, P = 0.02, Figure 4.19B). Next, we separated the colocalized microglia into 
ramified and hypertrophic to find that the percentage of lipofuscin-containing microglia in 
ramified microglia was increased in cognitively impaired animals (t(20) = 3.56, P = 0.001, 
Figure 4.19C), the percentage of hypertrophic microglia containing lipofuscin was not 
statistically different between cognitive groups (t(20) = 1.27, P = 0.11, Figure 4.19D). 
 To determine if these same results could be detected quantitatively, we used soma 
size volumes to determine differences in microglial co-localization with lipofuscin. First, 
we analyzed the volume of individual somas from 4 cognitively spared (CII < 2) and 4 
cognitively impaired animals (CII > 2). Using a cluster analysis, soma sizes were 
categorized as "small" (soma volume < 140µm) and "large" (soma volume > 140µm). 
Using these criteria, we performed a within-subjects ANOVA to determine differences in 
the percentage of colocalized microglia by size ("small" or "large"), co-localization with 
lipofuscin (colocalized or not colocalized), and cognitive impairment (Spared: CII < 2, 
Impaired: CII > 2). There were significant differences in the percentage of microglia based 
on size (F(1,22) = 14.0, P = 0.001), co-localization with lipofuscin (F(1,22) = 10.8, P = 
0.003), and interactions between group and soma size (F(1,22) = 5.93, P = 0.023) and soma 
size and co-localization with lipofuscin (F(1,22) = 5.29, P = 0.031). To evaluate the 
significant interactions, we performed chi-square tests for independence for the 
percentages of microglia by cognitive impairment and soma size to find a significant 
relationship between these variables (χ2 = 18.5, P < 0.01). Microglia in spared animals were 
more likely to have small soma volumes than microglia from cognitively impaired animals. 
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However, we found no significant relationship between microglial morphology and 
lipofuscin (χ2 = 9.80, P = 0.22) nor between lipofuscin colocalization with microglia and 
cognitive impairment (χ2 = 6.5, P = 0.477).  
Lipofuscin colocalizes equally with OPCs and mature oligodendrocytes 
 To evaluate whether lipofuscin colocalized with oligodendrocyte precursor cells 
(OPCs, see Figure 4.20A) or mature myelinating oligodendrocytes (see Figure 4.20B), we 
again used the Coloc2 plug-in for FIJI software to analyze markers for OPCs and mature 
oligodendrocytes (mOligos). We determined that there was no significant difference in 
lipofuscin co-localization with CC1 or PDGFRΑ as assessed by PCC (t(28) = 1.246, P = 
0.2267). Both markers demonstrated an age-related increased in correlation with lipofuscin 
(PDGF: F(1,27) = 6.36, P = 0.018, R2 = 0.161, Figure 4.20C; CC1: F(1,28) = 9.459, P = 
0.005, R2 = 0.226, Figure 4.20D). 
 For cognitive impairment, we divided middle-aged and old animals (ages 16+) into 
groups of cognitively spared (CII < 2) and cognitively impaired (CII > 2). We found no 
significant differences between groups in the amount of lipofuscin that colocalized with 
CC1 (t(22) = 0.10603, P = 0.45826) nor with PDGFRA (t(21) = 0.7556, P = 0.229).  
Autofluorescent lipofuscin is predominately associated with lysosomes 
 We hypothesized that autofluorescence was lipofuscin and would therefore be 
colocalized with lysosomes. We colabeled LAMP-1 (Figure 4.21A) with lipofuscin (Figure 
4.21B) to visualize co-localization (Figure 4.21C). Lipofuscin objects were segmented 
(Figure 4.21D) and applied to a corresponding LAMP-1 image (Figure 4.21E) to determine 
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the percent area of lipofuscin occupied with LAMP-1 (Figure 4.21F). Our analysis revealed 
that 96.7% (S.E. = 2.88%) of lipofuscin objects contained LAMP-1 staining.  
The emission profile of autofluorescence is primarily stimulated by 488nm lasers and 
561nm lasers, not far-red 633nm lasers 
 To characterize the nature of white matter autofluorescence, we determined the 
excitation/emission spectra of autofluorescence. We excited the tissue of each animal at 
488nm, 561nm, and 633nm and measured the emission profiles (Figure 4.22). At 488nm, 
the autofluorescence had two emission peaks with maximums at 520nm (Fluorescence 
Intensity (FI) = 25) and 600nm (FI =23) and minimal emission from 620nm to 730nm (FI 
= 1.1-7.1). With a 561nm laser, autofluorescence had two emission peaks at 600nm (FI = 
70) and 650nm (FI = 38) and declining emission from 660nm to 730nm (FI = 9.4). The 
633nm laser showed very little autofluorescence emission with no clear peak, but a 
maximal emission was recorded at 660nm (FI = 4.5). 
Discussion 
Summary 
 In this paper, we evaluated lipofuscin accumulation in frontal lobe white matter 
throughout the lifespan of the rhesus monkey. We measured lipofuscin accumulation to 
find an age-related increase in the amount and size of white matter lipofuscin. Interestingly, 
the cluster size, but not total amount, of lipofuscin increased with cognitive impairment. 
We next looked at glial cells to find that lipofuscin is primarily found in microglia and 
oligodendrocytes, but not astrocytes. In microglia, lipofuscin accumulation is not 
associated with a specific cellular morphology, but lipofuscin does appear to increase in 
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microglia with cognitive impairment. Lipofuscin is found in both oligodendrocyte 
precursor cells (OPCs) and mature oligodendrocytes (mOligos), but there is slight 
preference of lipofuscin for OPCs. Additionally, we characterized the lipofuscin 
autofluorescence to find that lipofuscin autofluoresces with excitation from a 488nm laser 
and a 561nm laser with emission spectra that ranged from 490nm to 700nm. A 633nm laser 
did not excite noticeable autofluorescence. Finally, we verified that autofluorescent 
lipofuscin was associated with lysosomes. 
Lipofuscin accumulation as evidence for lysosomal dysfunction and impaired autophagy  
 Lipofuscin is well-regarded as an accumulation that ubiquitously occurs with aging 
and correlates to longevity, giving it the moniker “the age pigment” (Brunk and Terman 
2002a). Therefore it was not surprising that we found lipofuscin to increase in density and 
size with age in the frontal white matter and cingulum bundle.  Lipofuscin in the brain has 
not been as well-studied as other regions of the body, especially the eye, and the white 
matter has been particularly overlooked. As lipofuscin accumulates in postmitotic cells, 
neuronal lipofuscin was investigated thoroughly. While lipofuscin was found in neurons, 
particularly large Betz cells (Tigges et al. 1990), there was no evidence for cellular 
dysfunction (Tigges et al. 1992) or neuronal loss (Vincent et al. 1989; Peters et al. 1991) 
suggesting that lipofuscin accumulation was merely a benign indicator of age. In contrast 
to this view, lipofuscin has been widely studied in the retina where it has been indicated in 
the progression of macular degeneration (Dorey et al. 1989; Bergmann et al. 2004) due to 
impaired lysosomal function (Holz et al. 1999), decreased autophagy (Saadat et al. 2014) 
and decreased phagocytosis (Ambati et al. 2013).  
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Similar dysfunction has been reported for fibroblasts burdened with lipofuscin 
(Terman et al. 1999a; Terman et al. 1999b; Stroikin et al. 2007), mesenchymal stem cells 
(Stolzing and Scutt 2006) and microglia (Safaiyan et al. 2016). Brunk and Terman (2002) 
suggested that cellular dysfunction arises in cells containing lipofuscin. Lipofuscin-
burdened cells direct lysosomal function towards degrading lipofuscin, using an abundance 
of limited lysosomal resources that leave the cell unable to cope with additional degradative 
functions required for normal autophagy. This results in further damage to the cell by 
inhibiting mitochondrial renewal and increasing oxidative damage. In the brain, Safaiyan 
et al (2016) found that the lipofuscin burden in microglia specifically reduced myelin 
phagocytosis. Additionally, lipofuscin particles in microglia were commonly associated 
with myelin basic protein. Based on our current data and our previous work (Chapters 2 
and 3; Shobin et al., 2017), we suggest that age-related myelin damage could be directly 
increasing lipofuscin accumulation in the brain. We suggest a feed-forward mechanism 
whereby myelin damage leads to increased lipofuscin, thereby impairing phagocytic 
properties of microglia and inhibiting myelin repair (Kotter et al. 2006). Thus, the increased 
presence of lipofuscin in the aged monkey white matter likely indicates a decrease cellular 
functionality.  
Lipofuscin burden associated with age-related cognitive impairment 
We found that while total lipofuscin density does not change in age-related 
cognitive impairment, there is an increase in the size of lipofuscin clusters in both the CGB 
and the FWM. This suggests that in cognitively spared animals, lipofuscin is distributed 
more evenly between cells, whereas cognitively impaired animals contain single cells that 
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are burdened with a greater lipofuscin load. Lipofuscin can decrease autophagy and 
eventually inhibit lysosomal function by demanding a large amount of degradative 
enzymes (Brunk and Terman, 2002a). In cognitive impairment, it is possible that certain 
cells vulnerable to lipofuscin accumulation would have a greater degree of functional loss 
compared with cells that contain little or no lipofuscin.  
As more lipofuscin accumulates within a cell and normal autophagy is inhibited, 
organelles within the cell that would be normally turned over, such as mitochondria are left 
in place and can become dysfunctional (Bratic and Larsson 2013). Damaged mitochondria 
can produce more ROS and can contain larger amounts of iron. Byproducts of damaged 
mitochondria (ROS and iron; see Bratic and Larsson, 2013) can then induce lipofuscin 
formation by oxidizing and cross-linking proteins, thereby creating a feed-forward loop 
where cells become more sensitive ROS and accumulate lipofuscin and damaged 
mitochondria which create more ROS (Brunk and Terman 2002b). Cells in cognitively 
impaired animals that contain a greater load of lipofuscin would be therefore more 
susceptible to oxidative damage and eventual cellular dysfunction  
Cellular vulnerability to lipofuscin accumulation: microglia and oligodendrocytes 
 Both microglia and oligodendrocytes are necessary components of remyelination 
after damage (Kotter et al. 2005; Lampron et al. 2015). As myelin is turned over regularly 
throughout life (Ando et al. 2003; Yeung et al. 2014), microglia and oligodendrocytes work 
in close concert to keep the system intact. With semi-regular myelin protein recycling, 
those proteins within microglia and oligodendrocytes could be easily oxidized and 
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aggregated as lipofuscin. As lipofuscin can impair normal lysosomal function, the impacts 
on these cells and the balance of normal myelin turnover could be severely disrupted. 
 Microglia become increasingly phagocytic with age likely in response to myelin 
damage (Shobin et al. 2017), but phagocytosing myelin debris increases lipofuscin in 
microglial cells (Safaiyan et al. 2016), potentially leading to a decrease in phagocytic 
functionality that could result in the reported increased ROS production and inflammation 
(Sierra et al. 2007; Norden and Godbout 2013; Vida et al. 2017). These dysfunctions could 
in turn lead to more myelin damage in a vicious cycle that continuously weakens the 
functionality of the microglia attempting to resolve the problem.  
 Like microglia, oligodendrocyte function is thought to decrease with age. Similar 
to our findings of lipofuscin in oligodendrocytes of the white matter, gray matter 
oligodendrocytes accumulate age-related dense inclusions resembling lipofuscin (Peters et 
al. 1991; Peters 1996; Peters and Sethares 2004). that may stress oligodendrocytes and lead 
to myelin damage seen in normal aging (Peters 2009). This stress may lead to RNA 
sequestration (Vanderweyde et al. 2013) that would disrupt stable myelin formation (Baron 
and Hoekstra 2010; Müller et al. 2013). Additionally, oxidation can cause DNA damage in 
oligodendrocytes that is thought to decrease both myelination remodeling capacity and 
oligodendrocyte precursor cell differentiation (see Tse and Herrup 2017). Indeed, 
oligodendrocytes from old animals are less effective at remyelinating than are 
oligodendrocytes from young animals (Shields et al. 1999). These differences in 
functionality are thought to arise from impaired precursor recruitment and differentiation 
  
94 
(Sim et al. 2002), suggesting that both mature oligodendrocytes and oligodendrocyte 
precursor cells are intrinsically affected by aging.  
Therapeutic potential 
 If these suggested mechanisms are correct, reversing lipofuscin accumulation may 
be an important strategy in improving longevity and reducing cognitive decline. For 
example, calorie restriction, an effective treatment for improving lifespan in worms, fruit 
flies, mice, rats (Heilbronn and Ravussin 2003) and monkeys (Mattison et al. 2012) is 
thought to work by increasing autophagy (Ferreira-Marques et al. 2016) and preserving 
mitochondrial function (Nisoli et al. 2005; López-Lluch et al. 2006; Lanza et al. 2012). 
Interestingly, calorie restriction has been shown to reduce lipofuscin accumulation in mice 
(Moore et al. 1995; Opalach et al. 2010). These results suggest further evidence for the role 
of lipofuscin in autophagy, but further research into the mechanistic connection is 
necessary to identify beneficial therapeutic targets. 
Conclusions 
  Myelin defects appear more commonly with age, but the mechanism is still unclear. 
Our results provide novel data on the glial-specific localization of lipofuscin aggregates in 
frontal white matter regions vulnerable to myelin damage. We propose a feed-forward 
mechanism where lipofuscin aggregates may impair autophageal/lysosomal function in 
microglia and oligodendrocytes. In microglia, this would impair the capacity of the 
phagocytes to remove and properly degrade myelin debris. In oligodendrocytes, protein 
oxidation could be impairing proper trafficking of myelin proteins required for proper 
remyelination. As these cells become less effective, the myelin turnover cycle is 
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overwhelmed and dysregulated, thus leading to accumulation of myelin damage. This 
myelin damage signals for increased inflammation, phagocytosis and myelin repair, which 
is unable to occur as more cells are burdened by lipofuscin. Future research on the 
mechanistic affects testing the effects of lipofuscin on microglial phagocytosis and myelin 
formation could provide new therapeutic routes to curb the cognitive effects of aging.   
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Figure 4.14. Lipofuscin increases with age in the white matter. Example autofluorescence 
was visualized using confocal microscopy in the frontal white matter (FWM) of A) a young 
monkey and B) an old monkey. Autofluorescent particles were quantified to determine the 
density of particle coverage (percent area) as a function of age. Scatter plots and linear 
regression analyses show that autofluorescence in the brain white matter accumulates with 
age in C) the FWM, but not the D) cingulum bundle (CGB). Additionally, 3D object 
analysis was used to evaluate the average volume of individual autofluorescent objects. 
  
97 
Scatter plots and linear regression analyses show that the average object volume increased 
as a function of age in both E) the FWM and F) the CGB.  
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Figure 4.15. Lipofuscin objects increase in volume with cognitive impairment. All 
monkeys received a battery of behavioral tests used to give a single z-score value called 
the Cognitive Impairment Index (CII). Middle-aged and old monkeys (ages 16+) were 
grouped into cognitively spared (CII < 2) and cognitively impaired (CII > 2) subjects. 
Example images of autofluorescence in FWM of A) a cognitively spared and B) a 
cognitively impaired animal. C,D) Vertical scatter plot showing individual data from each 
animal (open circles) and mean data (black line) for autofluorescent particle density, as 
assessed by percent area and E,F) autofluorescent object size.  Autofluorescence percent 
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area did not differ between cognitive impairment groups in either C) the FWM or D) the 
CGB. However, compared to cognitively spared animals, cognitively impaired monkeys 
had significantly larger autofluorescent objects in both E) the FWM and F) the CGB. 
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Figure 4.16. Lipofuscin colocalizes with microglia and oligodendrocytes. 
Autofluorescence was colocalized with three glial markers in brains from 30 monkeys to 
determine in which cells accumulation was occurring in the white matter. Three glial 
markers (all labeled in green) were used to colocalize with lipofuscin (colored magenta): 
A) astrocytes were stained with GFAP, B) microglia were labeled with Iba1 C) and 
oligodendrocytes were marked with Olig2. Co-localization in all images is seen as a white 
color. D) Quantification of co-localization of each marker with lipofuscin using a Co-
localization Coefficient (CLC) index calculated from a pixel-by-pixel Pearson’s 
Correlation Coefficient of signal intensity between the two channels using coloc2 plug-in 
from FIJI. Vertical scatter plot shows individual data from each animal (open circles) and 
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mean data (black line). The average CLC of lipofuscin and Iba1 was significantly greater 
than the average CLC of lipofuscin and GFAP as well as the average CLC of lipofuscin 
and Olig2. The CLC of lipofuscin and Olig2 was also significantly greater than the average 
CLC of lipofuscin and GFAP. Scale Bar = 100um; *** P < 0.005 
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Figure 4.17. Age-related correlations of lipofuscin and glial markers. Scatter plots and 
linear regression analyses of lipofuscin-glial marker Co-localization Coefficients against 
age. A) Lipofuscin autofluorescence co-localization with astrocyte staining trended toward 
a statistically significant linear correlation with age. We found statistically significant age-
related increases in lipofuscin co-localization with B) microglial staining and C) 
oligodendrocyte staining. 
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Figure 4.18. Quantification of lipofuscin and microglial morphology. Microglia were 
stained with Iba1 and imaged with confocal microscopy. Cells were manually counted to 
determine if microglia morphology related to lipofuscin accumulation. Microglia were 
characterized as either A) ramified or B,C) hypertrophic, which include both hypertrophic 
(B) and amoeboid (C) morphologies. D) For each image taken, 1/4th of the image in the 
bottom right corner was digitally magnified for microglia morphological quantification. E) 
Microglia were counted as containing lipofuscin or containing no lipofuscin and either 
ramified (blue circles) or hypertrophic (yellow circles). A-C: Scale bar = 10um; D, E: Scale 
bar = 50um   
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Figure 4.19. Hypertrophic microglia containing lipofuscin increase with CII. A) Scatter 
plot and linear regressions of percent of lipofuscin-containing microglia by morphological 
type against age. The percentage of microglia characterized as having a hypertrophic 
morphology increased with age. B-D) Vertical scatter plots showing individual data from 
each animal (open circles) and average data (black line): B) The mean percentage of total 
microglia that contained lipofuscin was greater in cognitively-impaired compared to 
cognitively-spared middle-aged and elderly animals. When determining differences in 
lipofuscin correlation by morphology, we found that C) the mean percentage of ramified 
microglia that contained lipofuscin was significantly greater in cognitively impaired 
animals, however, D) the mean percentage of hypertrophic microglia that contained 
lipofuscin did not significantly differ with cognitive impairment. 
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Figure 4.20. Lipofuscin co-localization with oligodendrocyte subtypes A,B) Representative 
confocal z-projection images showing that lipofuscin was colocalized with A) oligodendrocyte 
precursor cells (OPCs, PDGF) and B) mature oligodendrocytes (mOligos, CC1). There were 
no significant differences between the two markers in their extent of co-localization (co-
localization coefficients: PGDF/lipofuscin = 0.278; CC1/lipofuscin = 0.305) with lipofuscin.  
C,D) Scatter plots and linear regressions of co-localization coefficients of each marker with 
lipofuscin against age. Age was significantly correlated with lipofuscin co-localization for both 
C) PDGF and D) CC1. Scale Bar = 100um   
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Figure 4.21. Lipofuscin co-localization with lysosomes. To verify that autofluorescent 
lipofuscin was found lysosomes, we labeled tissue sections from 9 animals with A) LAMP-
1 and co-imaged this stain with B) lipofuscin to identify C) co-localization. Z-stacked 
images were separated by slice and channel. D) The lipofuscin channel was then 
thresholded to get regions of interest (outlined in yellow). E) These regions of interest were 
overlaid onto the corresponding LAMP-1 stained image. F) The area stained within the 
regions of interest could then be analyzed. We found that 96.7% of the lipofuscin regions 
were stained with LAMP-1, verifying that the autofluorescent lipofuscin was related to 
lysosomes.   
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Figure 4.22. Autofluorescence spectra profiles in the white matter. The emission profiles 
of autofluorescence were recorded using a lambda scan after laser stimulation from one of 
three lasers (488nm, 561nm, and 633nm). The average fluorescence intensity was taken 
from 30 animals at each wavelength to determine the emission profile. Stimulation with an 
argon 488nm laser provides a double-peaked emission spectra with maximums at 520nm 
and 60nm. Emissions after stimulation with the 561nm laser showed the strongest peaks 
with maximums at 600nm and 650nm. The 633nm laser showed very little detectable 
autofluorescence with no clear peak. Standard error is presented at each point.  
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
Summary of Results 
 In the previous chapters, we presented evidence for age-related impairment of myelin 
clearance and the potential processes underlying this dysfunction. First, we looked at a 
label-free method for myelin detection in the brain, Spectral Confocal Reflectance (SCoRe) 
imaging. Using SCoRe, we found that the percentage of reflectance did not differ with age, 
but, in old animals, reflectance was significantly decreased in cognitively impaired 
animals. Next, we found that myelin basic protein (MBP) in the cerebrospinal fluid (CSF) 
increased with age. Surprisingly, the concentration of MBP in the CSF was highest in old 
animals without cognitive impairment and old cognitively impaired animals had 
significantly less MBP in the CSF. In the old animals, the concentration of MBP in the 
CSF directly correlated with the amount of SCoRe signal in the brain. We then looked to 
gene expression to find that MBP expression in lateral prefrontal cortex increased with age. 
Next, we found that LN3 cells, a marker for microglial “activation”, and galectin-3 (Gal-
3) cells, a marker of phagocytic activation, increased with age in the frontal white matter 
regions. Gal-3 cells, but not LN3 cells, increased with cognitive impairment, specifically 
in the hypertrophic and amoeboid morphologies that are correlated with microglial 
“activation”. To determine any potential cause for cellular functional impairment, we next 
looked at accumulation of lipofuscin in the frontal white matter. We found that lipofuscin 
increases in density and size with age, and the size of lipofuscin clusters correlates with 
cognitive impairment. We determined that lipofuscin was primarily found in microglia and 
oligodendrocytes. The percentage of microglia that contained lipofuscin increased with 
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cognitive impairment. Both oligodendrocyte precursor cells (OPCs) and mature 
myelinating oligodendrocytes contained lipofuscin, with slightly more OPCs containing 
lipofuscin. Finally, we verified that lipofuscin was found inside lysosomes, with 96% of 
lipofuscin autofluorescence colocalized with the lysosomal marker LAMP-1. 
Looking beyond immunohistochemistry in the aging monkey 
 In the current work, immunohistochemistry (IHC) has been the predominant method 
utilized. IHC and histology provide unique information about localization, regionalization, 
cellular morphology and co-localization between proteins. Indeed, the current studies have 
made use of these characteristics to give an anatomical overview of the systems involved 
in age-related cognitive impairment and the myelin pathology in the rhesus monkey. While 
we have shown that white matter microglial phagocytic activity and lipofuscin 
accumulation are related to aging and cognitive decline, future work is needed to address 
the functional changes underlying these correlations.  
 In the following sections, will propose novel functional experiments to conduct using 
the rhesus monkey as a model for aging and cognitive impairment. Although both in vitro 
and rodent models are traditionally used for functional assays, each has significant 
drawbacks to consider in comparison to working with rhesus monkeys. In cell culture, 
microglia quickly lose their cellular signature (Gosselin et al. 2017) and are known to act 
in a context dependent manner, with vast gene expression differences throughout the brain 
(Grabert et al. 2016; Tay et al. 2017). Thus, removing microglia and other glial cells out of 
the environment of the aging brain is likely to significantly alter gene expression and 
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function, so every effort must be made to assess the functionality of these cells within the 
tissue. 
  In rodents, live imaging has led to a re-evaluation of microglial function outside of 
immunity, stemming from the seminal paper from Nimmerjahn and colleagues ( 2005). 
More recently, tagging the microglial-specific Cx3cr1 gene with green fluorescent protein 
(GFP) has been widely used as a method of in vivo microglial identification and 
functionality (Butovsky et al. 2014; Bennett et al. 2016). These techniques make the rodent 
a good model to address cortical function of microglia in health and disease. However, in 
terms of age-related white matter pathology, the rodent brain lacks a comparible amount 
of white matter (10%) to the human (37%) (Zhang and Sejnowski 2000). Additionally, 
mice and human microglial profiles diverge with age, with human microglia having altered 
gene expression related to neurodegenerative disease, such as those involved in cell 
adhesion, axonal guidance, and the microglial sensome that are distinct from the gene 
expression changes seen in the aging mouse (Galatro et al. 2017; Gosselin et al. 2017). 
Thus, using a monkey (36% white matter, Zhang and Sejnowski 2000) could prove to be a 
better model in understanding the subtle myelination changes that occur with aging and 
cognitive decline. 
Evaluating complex cellular interactions with RNA-sequencing 
 Traditionally, macrophage activation has been divided into states of pro-inflammatory 
(M1) and anti-inflammatory (M2) with a general consensus that M1 activation is increased 
in the brain with age (Norden and Godbout 2013). However, this dichotomy is too 
simplistic to represent the dynamic responses of microglia (Ransohoff 2016). While 
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immunohistochemistry limits our analyses to single proteins, gene expression profiling has 
begun to uncover the complexity of microglial and macrophage responses to age and 
disease (Wes et al. 2016). Using RNA sequencing (RNAseq), Hickman et al (2013) found 
an age-related shift towards transcripts involved in neuroprotection, however others have 
reported an increase in phagocytic, lysosomal and antigen-presentation transcripts 
(Holtman et al. 2015). Thus far, most RNAseq studies are limited to mouse brains which 
consist of 90% gray matter (Zhang and Sejnowski 2000) or human cortical tissue, limiting 
our knowledge of neuroimmune cells in white matter pathology.  
 Although the brain was once believed to be an isolated and privileged immune site, 
recent research has found that communication and recruitment of peripheral innate and 
adaptive immune cells is highly important in response to damage. Most notably, bone 
marrow derived macrophages (BMDM) are recruited to the adult brain (Vallieres and 
Sawchenko 2003; Cogle et al. 2004) and can enhance remyelination (Ruckh et al. 2012). 
BMDMs have distinct gene expression profiles from microglia (Hickman et al. 2013; 
Butovsky et al. 2014) and may be more effective phagocytes, but less capable of degrading 
debris such as myelin (Greenhalgh and David 2014) and potentially more inflammatory 
than microglia (Simard et al. 2006). Additionally, T-lymphocytes are recruited to the brain 
in aging and AD (Stichel and Luebbert 2007; Gemechu and Bentivoglio 2012) and may 
impact disease progression (Dansokho et al. 2016). Yet the role of these cells in influencing 
myelin pathology and cognitive impairment is unknown.  
 As macrophages are necessary for OPC maturation (Miron et al. 2013), but 
macrophages show gene expression and functional changes with age, it is no surprise that 
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OLs also exhibit age-related changes. Human brains show an age-related decrease in OLs 
(Pelvig et al. 2008; Fabricius et al. 2013) and impairment of OPC recruitment and 
differentiation (Sim et al. 2002). Additionally, DNA damage accrues with age in mature 
OLs, which could further impact myelin gene expression (Tse and Herrup 2017). Together, 
these data suggest that changes in OL gene expression profiles are likely to be involved in 
age-related myelin pathology.  
 We propose to use cognitive tested rhesus monkeys to evaluate gene mRNA expression 
profiles of microglia, peripheral macrophages, CD3+ lymphocytes, OPC and OLs. Unlike 
previous studies of aging and neuroimmune cells, this proposed study would utilize 
RNAseq to evaluate differences in gene expression in the white matter. Using archived 
frozen tissue from the frontal white matter of behaviorally tested rhesus monkeys from 
across the age range, gene expression could be correlated with age-related cognitive decline 
and myelin pathology. A study of this nature would be able to provide an in depth look at 
the complex gene expression changes in the monkey white matter to compare with what is 
known from humans and mice. These data could provide a bridge to understand the myelin 
pathology of aging seen in humans, while highlighting the protections monkeys have from 
age-related neurodegenerative diseases. 
Novel assays to assess connections of aging, lipofuscin and phagocytic capacity using the 
rhesus monkey 
 Myelin damage is the major pathology of aging and cognitive impairment (Peters and 
Rosene 2003). As myelin debris can inhibit remyelination (Kotter et al. 2006), removal of 
damaged myelin is imperative for restoration. Macrophages are necessary for myelin 
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phagocytosis (Neumann et al. 2009; Napoli and Neumann 2009; Safaiyan et al. 2016) and 
remyelination (Lampron et al. 2015). The results presented in this dissertation show that 
phagocytic priming of microglia in the frontal white matter increases with both age and 
cognitive impairment (Shobin et al. 2017). However, the phagocytic efficiency of 
microglia is decreased with age (Natrajan et al. 2015) possibly due to overburdened and 
inefficient degradative capacity (Safaiyan et al, 2016). Additionally, aged myelin may be 
less susceptible to phagocytosis (Hendrickx et al. 2014). 
 To address functionality of the phagocytic response to myelin damage in aging, we 
propose a novel ex vivo phagocytosis assay adapted from Hendrickx et al. 2014. Myelin 
can be isolated and purified from archived brain tissue of young, old cognitively spared, 
and old cognitively impaired monkeys and labeled with Alexa Fluor 633. Slices of freshly 
harvested monkey frontal white matter can then be incubated for separately with myelin 
from each category of subject. After incubation, slices can be fixed and visualized with 
immunofluorescence to quantify phagocytosis of myelin within microglia (stained with 
Iba1 and Gal-3) in relationship to age and cognitive impairment. Additionally, cells could 
be evaluated for lipofuscin content. Alternatively, tissue could be processed for FACS prior 
to fixation. Here, cells could be labeled with and gated for microglia (Iba1 or Gal-3), myelin 
(Alexa Fluor 633), lipofuscin (autofluorescence). The major advantage of using FACS is 
that cells could be sorted and gene expression differences evaluated using either RNA 
sequencing or screened using qPCR. Both of these methods would allow for direct 
quantification of myelin phagocytosis and test the hypotheses that 1) phagocytic 
functionality is impaired in normal aging, 2) myelin debris is less efficiently cleared in 
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white matter of aged compared to young monkeys and 3) lipofuscin impairs phagocytic 
capacity of microglia. These resutls would elucidate the mechanistic connection between 
microglial phagocytosis and lipofuscin accumulation in age-related myelin pathology. 
Functional capacity of OPCs to differentiate and repair myelin in aging 
 Although the neuroimmune system is imperitive in influencing oligodendrocyte 
precursor cell (OPC) maturation and differentiation (Miron et al. 2013), it is possible that 
oligodendrocytes themselves are dysfunctional. Remyelination appears to be slower with 
in aged rodent models of demyelination (Shields et al. 1999; Ruckh et al. 2012). As 
expected with increased inflammation, OPC recruitment and differentiation are impaired 
with age (Sim et al. 2002). Additionally, there may be a decrease in total number of OLs 
with age in humans (Fabricius et al. 2013; Soreq et al. 2017) as well as decreased 
expression of OL-specific transcripts (Soreq et al, 2017). Finally, our results demonstrated 
that both OPCs and mature oligodendrocytes accumulate lipofuscin with age, yet the 
functional role of lipofuscin in oligodendrocyte function is unknown. 
 We propose to test whether OPC differentiation is intrinsically impaired with age or 
extrinsically inhibited by macrophages from elderly monkeys and correlated with cognitive 
impairment. This can be tested by isolating OPCs from frontal white matter of monkeys 
from across the lifespan and 1) assaying their ability to differentiate in vitro alone, 2) and 
while co-cultured with microglia isolated from young and old monkey brains, and 3) 
following transplantation into cultured brain tissue from myelin-lacking shiverer mice. The 
first experiment will test the hypothesis that OPC differentiation is impaired with age 
whereas the second experiment tests the hypothesis that age-related microglia alterations 
  
115 
inhibit OPC differentiation. Differentiation can be quantified by measuring relative 
numbers of OPCs to mature oligodendrocytes after providing differentiation factors. 
Further, we can assess lipofuscin accumulation within the cells and deteremine whether 
OPCs containing lipofuscin had altered differentiation. In the third experiment, we can test 
the hypothesis that the remyelination capacity of oligodendrocytes is imapired with age 
using a model adapted from Bin et al. 2012. The shiverer mouse is hypomyelinated due to 
a lack of myelin basic protein gene (Kimura et al. 1989) but can be remyelinated by 
transplantation of oligodendrocytes that contain the myelin basic protein gene (Bin et al. 
2012). Using this model, we can measure the extent of myelination from oligodendrocytes 
isolated from young and old animals. Together, these results would indicate the effect of 
age, microglia and lipofuscin on oligodendrocyte function and potentially elucidate novel 
therapeutic targets to combat aging and age-related cognitive decline.  
Conclusions 
 In the preceding sections, we have demonstrated that damaged myelin clearance may 
be impaired in aging and cognitive decline, possibly due to the accumulation of lipofuscin. 
With our results, we have developed the following working model for age-related myelin 
pathology: normal myelin turnover throughout life aids in the aggregation of lipofuscin 
clusters and leads to the cellular impairment of microglia and oligodendrocytes. As 
microglia become dysfunctional with age, they are unable to remove and clear myelin 
debris from normal myelin turnover as quickly as was once possible. Myelin debris inhibits 
remyelination (Kotter et al. 2006) and oligodendrocytes and OPCs are halted in their 
normal function. Oligodendrocytes ready to remyelinate, are instead forced to sequester 
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their myelin proteins, potentially leading to the formation of oligodendrocyte lipofuscin 
and further cellular dysfunction. In healthy aging, massive amounts of myelin debris are 
effectively removed as seen by the presence of MBP in the CSF, whereas cognitively 
impaired agers are left with lingering myelin debris, causing further damage and improper 
restoration of functional myelin sheaths. The future studies proposed in this chapter are 
designed to test this model and to discover novel therapuetic targets to treat the conditions 
of both normal aging and age-related cognitive decline.  
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